| Year |
Citation |
Score |
| 2016 |
Spaulding EL, Sleigh JN, Morelli KH, Pinter MJ, Burgess RW, Seburn KL. Synaptic Deficits at Neuromuscular Junctions in Two Mouse Models of Charcot-Marie-Tooth Type 2d. The Journal of Neuroscience : the Official Journal of the Society For Neuroscience. 36: 3254-67. PMID 26985035 DOI: 10.1523/Jneurosci.1762-15.2016 |
0.304 |
|
| 2015 |
Carrasco DI, Seburn KL, Pinter MJ. Altered terminal Schwann cell morphology precedes denervation in SOD1 mice. Experimental Neurology. PMID 26416261 DOI: 10.1016/j.expneurol.2015.09.014 |
0.318 |
|
| 2015 |
Novak KR, Norman J, Mitchell JR, Pinter MJ, Rich MM. Sodium channel slow inactivation as a therapeutic target for myotonia congenita. Annals of Neurology. 77: 320-32. PMID 25515836 DOI: 10.1002/ana.24331 |
0.308 |
|
| 2012 |
Carrasco DI, Bichler EK, Rich MM, Wang X, Seburn KL, Pinter MJ. Motor terminal degeneration unaffected by activity changes in SOD1(G93A) mice; a possible role for glycolysis. Neurobiology of Disease. 48: 132-40. PMID 22750521 DOI: 10.1016/j.nbd.2012.06.017 |
0.458 |
|
| 2011 |
Bullinger KL, Nardelli P, Pinter MJ, Alvarez FJ, Cope TC. Permanent central synaptic disconnection of proprioceptors after nerve injury and regeneration. II. Loss of functional connectivity with motoneurons. Journal of Neurophysiology. 106: 2471-85. PMID 21832030 DOI: 10.1152/Jn.01097.2010 |
0.729 |
|
| 2011 |
Prather JF, Nardelli P, Nakanishi ST, Ross KT, Nichols TR, Pinter MJ, Cope TC. Recovery of proprioceptive feedback from nerve crush. The Journal of Physiology. 589: 4935-47. PMID 21788349 DOI: 10.1113/Jphysiol.2011.210518 |
0.696 |
|
| 2010 |
Carrasco DI, Bichler EK, Seburn KL, Pinter MJ. Nerve terminal degeneration is independent of muscle fiber genotype in SOD1 mice. Plos One. 5: e9802. PMID 20339550 DOI: 10.1371/journal.pone.0009802 |
0.341 |
|
| 2007 |
Bichler EK, Nakanishi ST, Wang QB, Pinter MJ, Rich MM, Cope TC. Enhanced transmission at a spinal synapse triggered in vivo by an injury signal independent of altered synaptic activity. The Journal of Neuroscience : the Official Journal of the Society For Neuroscience. 27: 12851-9. PMID 18032657 DOI: 10.1523/Jneurosci.1997-07.2007 |
0.754 |
|
| 2007 |
Bichler EK, Carrasco DI, Rich MM, Cope TC, Pinter MJ. Rat motoneuron properties recover following reinnervation in the absence of muscle activity and evoked acetylcholine release. The Journal of Physiology. 585: 47-56. PMID 17884931 DOI: 10.1113/jphysiol.2007.135541 |
0.701 |
|
| 2006 |
Wang X, Engisch KL, Teichert RW, Olivera BM, Pinter MJ, Rich MM. Prolongation of evoked and spontaneous synaptic currents at the neuromuscular junction after activity blockade is caused by the upregulation of fetal acetylcholine receptors. The Journal of Neuroscience : the Official Journal of the Society For Neuroscience. 26: 8983-7. PMID 16943554 DOI: 10.1523/Jneurosci.2493-06.2006 |
0.348 |
|
| 2005 |
Haftel VK, Bichler EK, Wang QB, Prather JF, Pinter MJ, Cope TC. Central suppression of regenerated proprioceptive afferents. The Journal of Neuroscience : the Official Journal of the Society For Neuroscience. 25: 4733-42. PMID 15888649 DOI: 10.1523/Jneurosci.4895-04.2005 |
0.786 |
|
| 2005 |
Nakanishi ST, Cope TC, Rich MM, Carrasco DI, Pinter MJ. Regulation of motoneuron excitability via motor endplate acetylcholine receptor activation. The Journal of Neuroscience : the Official Journal of the Society For Neuroscience. 25: 2226-32. PMID 15745948 DOI: 10.1523/Jneurosci.5065-04.2005 |
0.759 |
|
| 2005 |
Wang X, Li Y, Engisch KL, Nakanishi ST, Dodson SE, Miller GW, Cope TC, Pinter MJ, Rich MM. Activity-dependent presynaptic regulation of quantal size at the mammalian neuromuscular junction in vivo. The Journal of Neuroscience : the Official Journal of the Society For Neuroscience. 25: 343-51. PMID 15647477 DOI: 10.1523/Jneurosci.3252-04.2005 |
0.732 |
|
| 2004 |
Wang X, Engisch KL, Li Y, Pinter MJ, Cope TC, Rich MM. Decreased synaptic activity shifts the calcium dependence of release at the mammalian neuromuscular junction in vivo. The Journal of Neuroscience : the Official Journal of the Society For Neuroscience. 24: 10687-92. PMID 15564585 DOI: 10.1523/JNEUROSCI.2755-04.2004 |
0.583 |
|
| 2004 |
Carrasco DI, Rich MM, Wang Q, Cope TC, Pinter MJ. Activity-driven synaptic and axonal degeneration in canine motor neuron disease. Journal of Neurophysiology. 92: 1175-81. PMID 15028742 DOI: 10.1152/jn.00157.2004 |
0.653 |
|
| 2004 |
Haftel VK, Bichler EK, Nichols TR, Pinter MJ, Cope TC. Movement reduces the dynamic response of muscle spindle afferents and motoneuron synaptic potentials in rat. Journal of Neurophysiology. 91: 2164-71. PMID 14695354 DOI: 10.1152/Jn.01147.2003 |
0.714 |
|
| 2002 |
Rich MM, Wang X, Cope TC, Pinter MJ. Reduced neuromuscular quantal content with normal synaptic release time course and depression in canine motor neuron disease. Journal of Neurophysiology. 88: 3305-14. PMID 12466448 DOI: 10.1152/jn.00271.2002 |
0.668 |
|
| 2002 |
Rich MM, Waldeck RF, Cork LC, Balice-Gordon RJ, Fyffe RE, Wang X, Cope TC, Pinter MJ. Reduced endplate currents underlie motor unit dysfunction in canine motor neuron disease. Journal of Neurophysiology. 88: 3293-304. PMID 12466447 DOI: 10.1152/Jn.00270.2002 |
0.642 |
|
| 2000 |
Balice-Gordon RJ, Smith DB, Goldman J, Cork LC, Shirley A, Cope TC, Pinter MJ. Functional motor unit failure precedes neuromuscular degeneration in canine motor neuron disease. Annals of Neurology. 47: 596-605. PMID 10805330 DOI: 10.1002/1531-8249(200005)47:5<596::Aid-Ana7>3.0.Co;2-I |
0.686 |
|
| 1998 |
Rich MM, Pinter MJ, Kraner SD, Barchi RL. Loss of electrical excitability in an animal model of acute quadriplegic myopathy. Annals of Neurology. 43: 171-9. PMID 9485058 DOI: 10.1002/ana.410430207 |
0.307 |
|
| 1997 |
Pinter MJ, Waldeck RF, Cope TC, Cork LC. Effects of 4-aminopyridine on muscle and motor unit force in canine motor neuron disease. The Journal of Neuroscience : the Official Journal of the Society For Neuroscience. 17: 4500-7. PMID 9151766 DOI: 10.1523/Jneurosci.17-11-04500.1997 |
0.638 |
|
| 1996 |
Tantisira B, Alstermark B, Isa T, Kümmel H, Pinter M. Motoneuronal projection pattern of single C3-C4 propriospinal neurones. Canadian Journal of Physiology and Pharmacology. 74: 518-30. PMID 8828897 DOI: 10.1139/Y96-037 |
0.309 |
|
| 1995 |
Waldeck RF, Murphy EH, Pinter MJ. Properties of motor units after self-reinnervation of the cat superior oblique muscle. Journal of Neurophysiology. 74: 2309-18. PMID 8747193 |
0.424 |
|
| 1995 |
Pinter MJ, Waldeck RF, Wallace N, Cork LC. Motor unit behavior in canine motor neuron disease. The Journal of Neuroscience : the Official Journal of the Society For Neuroscience. 15: 3447-57. PMID 7751923 |
0.353 |
|
| 1995 |
Cope T, Pinter M. The Size Principle: Still Working After All These Years Physiology. 10: 280-286. DOI: 10.1152/PHYSIOLOGYONLINE.1995.10.6.280 |
0.569 |
|
| 1993 |
Vanden Noven S, Wallace N, Muccio D, Turtz A, Pinter MJ. Adult spinal motoneurons remain viable despite prolonged absence of functional synaptic contact with muscle. Experimental Neurology. 123: 147-56. PMID 8405274 DOI: 10.1006/exnr.1993.1147 |
0.415 |
|
| 1992 |
Alstermark B, Pinter MJ, Sasaki S, Tantisira B. Trigeminal excitation of dorsal neck motoneurones in the cat. Experimental Brain Research. 92: 183-93. PMID 1493860 DOI: 10.1007/BF00227964 |
0.336 |
|
| 1991 |
Pinter MJ, Vanden Noven S, Muccio D, Wallace N. Axotomy-like changes in cat motoneuron electrical properties elicited by botulinum toxin depend on the complete elimination of neuromuscular transmission. The Journal of Neuroscience : the Official Journal of the Society For Neuroscience. 11: 657-66. PMID 1848281 |
0.415 |
|
| 1989 |
Pinter MJ, Vanden Noven S. Effects of preventing reinnervation on axotomized spinal motoneurons in the cat. I. Motoneuron electrical properties. Journal of Neurophysiology. 62: 311-24. PMID 2769333 |
0.424 |
|
| 1989 |
Vanden Noven S, Pinter MJ. Effects of preventing reinnervation on axotomized spinal motoneurons in the cat. II. Changes in group Ia synaptic function. Journal of Neurophysiology. 62: 325-33. PMID 2549206 |
0.403 |
|
| 1987 |
Alstermark B, Lundberg A, Pinter M, Sasaki S. Long C3-C5 propriospinal neurones in the cat. Brain Research. 404: 382-8. PMID 3032341 DOI: 10.1016/0006-8993(87)91400-4 |
0.311 |
|
| 1986 |
Gustafsson B, Pinter MJ, Wigström H. The effect of axotomy on posttetanic potentiation of group Ia synapses in the cat. Journal of Neurophysiology. 56: 1174-84. PMID 3023562 |
0.356 |
|
| 1985 |
Alstermark B, Pinter MJ, Sasaki S. Pyramidal effects in dorsal neck motoneurones of the cat. The Journal of Physiology. 363: 287-302. PMID 4020701 DOI: 10.1113/jphysiol.1985.sp015710 |
0.342 |
|
| 1985 |
Gustafsson B, Pinter MJ. Factors determining the variation of the afterhyperpolarization duration in cat lumbar alpha-motoneurones. Brain Research. 326: 392-5. PMID 3971165 DOI: 10.1016/0006-8993(85)90053-8 |
0.301 |
|
| 1985 |
O'Donovan MJ, Pinter MJ, Dum RP, Burke RE. Kinesiological studies of self- and cross-reinnervated FDL and soleus muscles in freely moving cats. Journal of Neurophysiology. 54: 852-66. PMID 2999350 DOI: 10.1152/Jn.1985.54.4.852 |
0.381 |
|
| 1985 |
Dum RP, O'Donovan MJ, Toop J, Tsairis P, Pinter MJ, Burke RE. Cross-reinnervated motor units in cat muscle. II. Soleus muscle reinnervated by flexor digitorum longus motoneurons. Journal of Neurophysiology. 54: 837-51. PMID 2999349 DOI: 10.1152/Jn.1985.54.4.837 |
0.372 |
|
| 1984 |
Gustafsson B, Pinter MJ. Effects of axotomy on the distribution of passive electrical properties of cat motoneurones. The Journal of Physiology. 356: 433-42. PMID 6520793 DOI: 10.1113/jphysiol.1984.sp015474 |
0.326 |
|
| 1984 |
Gustafsson B, Pinter MJ. Influence of post-synaptic properties on the time course of synaptic potentials in different types of cat lumbar alpha-motoneurons. Neuroscience Letters. 51: 67-72. PMID 6514233 DOI: 10.1016/0304-3940(84)90264-7 |
0.318 |
|
| 1983 |
Pinter MJ, Curtis RL, Hosko MJ. Voltage threshold and excitability among variously sized cat hindlimb motoneurons. Journal of Neurophysiology. 50: 644-57. PMID 6311995 |
0.319 |
|
| 1983 |
Lev-Tov A, Pinter MJ, Burke RE. Posttetanic potentiation of group Ia EPSPs: possible mechanisms for differential distribution among medial gastrocnemius motoneurons. Journal of Neurophysiology. 50: 379-98. PMID 6310059 DOI: 10.1152/Jn.1983.50.2.379 |
0.319 |
|
| 1983 |
Alstermark B, Pinter M, Sasaki S. Brainstem relay of disynaptic pyramidal EPSPs to neck motoneurons in the cat Brain Research. 259: 147-150. PMID 6297666 DOI: 10.1016/0006-8993(83)91078-8 |
0.311 |
|
| 1982 |
O'Donovan MJ, Pinter MJ, Dum RP, Burke RE. Actions of FDL and FHL muscles in intact cats: functional dissociation between anatomical synergists. Journal of Neurophysiology. 47: 1126-43. PMID 7108575 DOI: 10.1152/Jn.1982.47.6.1126 |
0.338 |
|
| 1982 |
Pinter MJ, Burke RE, O'Donovan MJ, Dum RP. Supraspinal facilitation of cutaneous polysynaptic EPSPs in cat medical gastrocnemius motoneurons. Experimental Brain Research. 45: 133-43. PMID 7056320 DOI: 10.1007/Bf00235772 |
0.358 |
|
| Low-probability matches (unlikely to be authored by this person) |
| 1987 |
Alstermark B, Lundberg A, Pinter M, Sasaki S. Vestibular effects in long C3-C5 propriospinal neurones. Brain Research. 404: 389-94. PMID 3567582 DOI: 10.1016/0006-8993(87)91401-6 |
0.299 |
|
| 1982 |
Burke RE, Dum RP, Fleshman JW, Glenn LL, Lev-Tov A, O'Donovan MJ, Pinter MJ. A HRP study of the relation between cell size and motor unit type in cat ankle extensor motoneurons. The Journal of Comparative Neurology. 209: 17-28. PMID 7119171 DOI: 10.1002/Cne.902090103 |
0.298 |
|
| 2003 |
Rich MM, Pinter MJ. Crucial role of sodium channel fast inactivation in muscle fibre inexcitability in a rat model of critical illness myopathy. The Journal of Physiology. 547: 555-66. PMID 12562930 DOI: 10.1113/jphysiol.2002.035188 |
0.295 |
|
| 2000 |
Chang Q, Pereda A, Pinter MJ, Balice-Gordon RJ. Nerve injury induces gap junctional coupling among axotomized adult motor neurons. The Journal of Neuroscience : the Official Journal of the Society For Neuroscience. 20: 674-84. PMID 10632597 |
0.289 |
|
| 1991 |
Pinter M, Vanden Noven S, Muccio D, Wallace N. Axotomy-like changes in cat motoneuron electrical properties elicited by botulinum toxin depend on the complete elimination of neuromuscular transmission The Journal of Neuroscience. 11: 657-666. DOI: 10.1523/jneurosci.11-03-00657.1991 |
0.288 |
|
| 1992 |
Alstermark B, Pinter MJ, Sasaki S. Descending pathways mediating disynaptic excitation of dorsal neck motoneurones in the cat: facilitatory interactions. Neuroscience Research. 15: 32-41. PMID 1336583 DOI: 10.1016/0168-0102(92)90015-5 |
0.285 |
|
| 2016 |
Carrasco DI, Bahr BA, Seburn KL, Pinter MJ. Abnormal response of distal Schwann cells to denervation in a mouse model of motor neuron disease. Experimental Neurology. PMID 26853136 DOI: 10.1016/j.expneurol.2016.02.002 |
0.278 |
|
| 2005 |
Filatov GN, Pinter MJ, Rich MM. Resting potential-dependent regulation of the voltage sensitivity of sodium channel gating in rat skeletal muscle in vivo. The Journal of General Physiology. 126: 161-72. PMID 16043776 DOI: 10.1085/jgp.200509337 |
0.276 |
|
| 2016 |
Wang X, Pinter MJ, Rich MM. Reversible Recruitment of a Homeostatic Reserve Pool of Synaptic Vesicles Underlies Rapid Homeostatic Plasticity of Quantal Content. The Journal of Neuroscience : the Official Journal of the Society For Neuroscience. 36: 828-36. PMID 26791213 DOI: 10.1523/JNEUROSCI.3786-15.2016 |
0.268 |
|
| 1992 |
Alstermark B, Pinter MJ, Sasaki S. Tectal and tegmental excitation in dorsal neck motoneurones of the cat. The Journal of Physiology. 454: 517-32. PMID 1474501 |
0.265 |
|
| 1993 |
Itoh Y, Tessler A, Kowada M, Pinter M. Electrophysiological responses in foetal spinal cord transplants evoked by regenerated dorsal root axons. Acta Neurochirurgica. Supplementum. 58: 24-6. PMID 8109295 |
0.251 |
|
| 1998 |
Green SL, Vulliet PR, Pinter MJ, Cork LC. Alterations in cyclin-dependent protein kinase 5 (CDK5) protein levels, activity and immunocytochemistry in canine motor neuron disease. Journal of Neuropathology and Experimental Neurology. 57: 1070-7. PMID 9825944 DOI: 10.1097/00005072-199811000-00010 |
0.25 |
|
| 1983 |
Alstermark B, Pinter M, Sasaki S. Convergence on reticulospinal neurons mediating contralateral pyramidal disynaptic EPSPs to neck motoneurons Brain Research. 259: 151-154. PMID 6297667 DOI: 10.1016/0006-8993(83)91079-X |
0.248 |
|
| 1996 |
Itoh Y, Waldeck RF, Tessler A, Pinter MJ. Regenerated dorsal root fibers form functional synapses in embryonic spinal cord transplants. Journal of Neurophysiology. 76: 1236-45. PMID 8871233 |
0.248 |
|
| 1987 |
Alstermark B, Lundberg A, Pinter M, Sasaki S. Subpopulations and functions of long C3-C5 propriospinal neurones. Brain Research. 404: 395-400. PMID 3567583 DOI: 10.1016/0006-8993(87)91402-8 |
0.229 |
|
| 2001 |
Rich MM, Pinter MJ. Sodium channel inactivation in an animal model of acute quadriplegic myopathy. Annals of Neurology. 50: 26-33. PMID 11456306 DOI: 10.1002/ana.1016 |
0.228 |
|
| 1992 |
Alstermark B, Pinter MJ, Sasaki S. Descending pathways mediating disynaptic excitation of dorsal neck motoneurones in the cat: brain stem relay. Neuroscience Research. 15: 42-57. PMID 1336584 DOI: 10.1016/0168-0102(92)90016-6 |
0.228 |
|
| 1990 |
Alstermark B, Kümmel H, Pinter MJ, Tantisira B. Integration in descending motor pathways controlling the forelimb in the cat. 17. Axonal projection and termination of C3-C4 propriospinal neurones in the C6-Th1 segments. Experimental Brain Research. 81: 447-61. PMID 2226681 DOI: 10.1007/BF02423494 |
0.219 |
|
| 1984 |
Gustafsson B, Pinter MJ. An investigation of threshold properties among cat spinal alpha-motoneurones. The Journal of Physiology. 357: 453-83. PMID 6512700 DOI: 10.1113/jphysiol.1984.sp015511 |
0.211 |
|
| 2009 |
Filatov GN, Pinter MJ, Rich MM. Role of Ca(2+) in injury-induced changes in sodium current in rat skeletal muscle. American Journal of Physiology. Cell Physiology. 297: C352-9. PMID 19494240 DOI: 10.1152/ajpcell.00021.2009 |
0.21 |
|
| 1999 |
Chang Q, Gonzalez M, Pinter MJ, Balice-Gordon RJ. Gap junctional coupling and patterns of connexin expression among neonatal rat lumbar spinal motor neurons. The Journal of Neuroscience : the Official Journal of the Society For Neuroscience. 19: 10813-28. PMID 10594064 |
0.203 |
|
| 1984 |
Gustafsson B, Pinter MJ. Relations among passive electrical properties of lumbar alpha-motoneurones of the cat. The Journal of Physiology. 356: 401-31. PMID 6520792 DOI: 10.1113/jphysiol.1984.sp015473 |
0.201 |
|
| 1987 |
Alstermark B, Kümmel H, Pinter MJ, Tantisira B. Branching and termination of C3-C4 propriospinal neurones in the cervical spinal cord of the cat. Neuroscience Letters. 74: 291-6. PMID 3561883 DOI: 10.1016/0304-3940(87)90312-0 |
0.191 |
|
| 1985 |
Gustafsson B, Pinter MJ. On factors determining orderly recruitment of motor units: a role for intrinsic membrane properties Trends in Neurosciences. 8: 431-433. DOI: 10.1016/0166-2236(85)90152-3 |
0.184 |
|
| 1996 |
Cork LC, Green S, Pinter MJ. PATHOLOGY OF END-STAGE HOMOZYGOUS HEREDITARY CANINE MOTOR NEURON DISEASE Journal of Neuropathology and Experimental Neurology. 55: 660. DOI: 10.1097/00005072-199605000-00229 |
0.17 |
|
| 2000 |
Pullium JK, Dillehay DL, Webb S, Pinter MJ. Congenital bilateral ureteral stenosis and hydronephrosis in a neonatal puppy. Contemporary Topics in Laboratory Animal Science / American Association For Laboratory Animal Science. 39: 34-6. PMID 11040873 |
0.159 |
|
| 2023 |
Scheiner B, Lampichler K, Pomej K, Beer L, Balcar L, Sartoris R, Bouattour M, Sidali S, Trauner M, Mandorfer M, Reiberger T, Scharitzer M, Tamandl D, Pinato DJ, Ronot M, ... Pinter M, et al. Transversal psoas muscle thickness measurement is associated with response and survival in patients with HCC undergoing immunotherapy. Hepatology Communications. 7. PMID 37708441 DOI: 10.1097/HC9.0000000000000261 |
0.153 |
|
| 2001 |
Green SL, Bouley DM, Pinter MJ, Cork LC, Vatassery GT. Canine motor neuron disease: clinicopathologic features and selected indicators of oxidative stress. Journal of Veterinary Internal Medicine / American College of Veterinary Internal Medicine. 15: 112-9. PMID 11300593 DOI: 10.1111/J.1939-1676.2001.Tb01241.X |
0.135 |
|
| 1997 |
Cork LC, Green SL, Pinter MJ. Hereditary canine spinal muscular atrophy: genetics, neurophysiology, and pathology. Journal of the Neurological Sciences. 152: S74. PMID 9419058 DOI: 10.1016/S0022-510X(97)00248-7 |
0.116 |
|
| 2009 |
Rubino T, Realini N, Braida D, Guidi S, Capurro V, Viganò D, Guidali C, Pinter M, Sala M, Bartesaghi R, Parolaro D. Changes in hippocampal morphology and neuroplasticity induced by adolescent THC treatment are associated with cognitive impairment in adulthood. Hippocampus. 19: 763-72. PMID 19156848 DOI: 10.1002/hipo.20554 |
0.102 |
|
| 2010 |
Wang X, Pinter MJ, Rich MM. Ca2+ dependence of the binomial parameters p and n at the mouse neuromuscular junction. Journal of Neurophysiology. 103: 659-66. PMID 19939953 DOI: 10.1152/jn.00708.2009 |
0.094 |
|
| 2020 |
Sladky VC, Knapp K, Szabo TG, Braun VZ, Bongiovanni L, van den Bos H, Spierings DC, Westendorp B, Curinha A, Stojakovic T, Scharnagl H, Timelthaler G, Tsuchia K, Pinter M, Semmler G, et al. PIDDosome-induced p53-dependent ploidy restriction facilitates hepatocarcinogenesis. Embo Reports. 21: e50893. PMID 33225610 DOI: 10.15252/embr.202050893 |
0.093 |
|
| 2018 |
Schick T, Schlake HP, Kallusky J, Hohlfeld G, Steinmetz M, Tripp F, Krakow K, Pinter M, Dohle C. Synergy effects of combined multichannel EMG-triggered electrical stimulation and mirror therapy in subacute stroke patients with severe or very severe arm/hand paresis. Restorative Neurology and Neuroscience. 35: 319-332. PMID 28506003 DOI: 10.3233/RNN-160710 |
0.092 |
|
| 1993 |
Tessler A, Goldberger ME, Himes BT, Howland DR, Itoh Y, Pinter MJ. Transplant mediated mechanisms of locomotor recovery. Restorative Neurology and Neuroscience. 5: 64-5. PMID 21551696 DOI: 10.3233/Rnn-1993-5117 |
0.085 |
|
| 1977 |
Rajala GM, Pinter MJ, Kaplan S. Response of the quiescent heart tube to mechanical stretch in the intact chick embryo. Developmental Biology. 61: 330-7. PMID 590630 DOI: 10.1016/0012-1606(77)90302-5 |
0.082 |
|
| 2015 |
Kortüm B, Campregher C, Lang M, Khare V, Pinter M, Evstatiev R, Schmid G, Mittlböck M, Scharl T, Kucherlapati MH, Edelmann W, Gasche C. Mesalazine and thymoquinone attenuate intestinal tumour development in Msh2loxP/loxP Villin-Cre mice. Gut. 64: 1905-12. PMID 25429050 DOI: 10.1136/Gutjnl-2014-307663 |
0.081 |
|
| 1971 |
Pintér M, Bende I, Domokos L. [The intracellular urease activity of Moraxella Iwoffi (Bacterium anitratum) group]. Zentralblatt Fur Bakteriologie, Parasitenkunde, Infektionskrankheiten Und Hygiene. 1. Abt. Medizinisch-Hygienische Bakteriologie, Virusforschung Und Parasitologie. Originale. 203: 387-90. PMID 5633600 |
0.081 |
|
| 2007 |
Hariz MI, Krack P, Alesch F, Augustinsson LE, Bosch A, Ekberg R, Johansson F, Johnels B, Meyerson BA, N'Guyen JP, Pinter M, Pollak P, von Raison F, Rehncrona S, Speelman JD, et al. Multicentre European study of thalamic stimulation for parkinsonian tremor: a 6 year follow-up. Journal of Neurology, Neurosurgery, and Psychiatry. 79: 694-9. PMID 17898034 DOI: 10.1136/jnnp.2007.118653 |
0.08 |
|
| 2020 |
Pinter M, Scheiner B, Peck-Radosavljevic M. Immunotherapy for advanced hepatocellular carcinoma: a focus on special subgroups. Gut. 70: 204-214. PMID 32747413 DOI: 10.1136/gutjnl-2020-321702 |
0.08 |
|
| 2023 |
Manfredi GF, Celsa C, John C, Jones C, Acuti N, Scheiner B, Fulgenzi CAM, Korolewicz J, Pinter M, Gennari A, Mauri FA, Pirisi M, Minisini R, Vincenzi F, Burlone M, et al. Mechanisms of Resistance to Immunotherapy in Hepatocellular Carcinoma. Journal of Hepatocellular Carcinoma. 10: 1955-1971. PMID 37941812 DOI: 10.2147/JHC.S291553 |
0.076 |
|
| 2009 |
Albini A, Brigati C, Ventura A, Lorusso G, Pinter M, Morini M, Mancino A, Sica A, Noonan DM. Angiostatin anti-angiogenesis requires IL-12: The innate immune system as a key target Journal of Translational Medicine. 7. PMID 19144161 DOI: 10.1186/1479-5876-7-5 |
0.067 |
|
| 2001 |
Kovács P, Pintér M. Effects of phosphoprotein phosphatase inhibitors (phenylarsine oxide and cantharidin) on Tetrahymena. Cell Biochemistry and Function. 19: 197-205. PMID 11494309 DOI: 10.1002/CBF.913 |
0.067 |
|
| 2015 |
Albanese A, Abbruzzese G, Dressler D, Duzynski W, Khatkova S, Marti MJ, Mir P, Montecucco C, Moro E, Pinter M, Relja M, Roze E, Skogseid IM, Timerbaeva S, Tzoulis C. Practical guidance for CD management involving treatment of botulinum toxin: a consensus statement. Journal of Neurology. PMID 25877834 DOI: 10.1007/S00415-015-7703-X |
0.066 |
|
| 2001 |
Kovács P, Pintér M, Csaba G. Effect of glucosphingolipid synthesis inhibitor (PPMP and PDMP) treatment on Tetrahymena pyriformis: data on the evolution of the signaling system. Cell Biochemistry and Function. 18: 269-80. PMID 11180290 DOI: 10.1002/1099-0844(200012)18:4<269::Aid-Cbf883>3.0.Co;2-H |
0.064 |
|
| 2017 |
Jung K, Heishi T, Incio J, Huang Y, Beech EY, Pinter M, Ho WW, Kawaguchi K, Rahbari NN, Chung E, Kim JK, Clark JW, Willett CG, Yun SH, Luster AD, et al. Targeting CXCR4-dependent immunosuppressive Ly6C(low) monocytes improves antiangiogenic therapy in colorectal cancer. Proceedings of the National Academy of Sciences of the United States of America. PMID 28900008 DOI: 10.1073/Pnas.1710754114 |
0.063 |
|
| 2010 |
Sator-Katzenschlager S, Fiala K, Kress HG, Kofler A, Neuhold J, Kloimstein H, Ilias W, Mozes-Balla EM, Pinter M, Loining N, Fuchs W, Heinze G, Likar R. Subcutaneous target stimulation (STS) in chronic noncancer pain: a nationwide retrospective study. Pain Practice : the Official Journal of World Institute of Pain. 10: 279-86. PMID 20230450 DOI: 10.1111/j.1533-2500.2009.00351.x |
0.061 |
|
| 1968 |
Pintér M, Bende I. Biochemical similarity of Acinetobacter lwoffii and Acinetobacter anitratus. Pathologia Et Microbiologia. 31: 41-5. PMID 5645620 |
0.06 |
|
| 2021 |
Jachs M, Hartl L, Simbrunner B, Bauer D, Paternostro R, Scheiner B, Schwabl P, Stättermayer AF, Pinter M, Eigenbauer E, Quehenberger P, Trauner M, Reiberger T, Mandorfer M. Decreasing VWF-levels upon NSBB-therapy indicate a decreased risk of further decompensation, ACLF, and death. Clinical Gastroenterology and Hepatology : the Official Clinical Practice Journal of the American Gastroenterological Association. PMID 34256145 DOI: 10.1016/j.cgh.2021.07.012 |
0.059 |
|
| 2023 |
Balcar L, Simbrunner B, Paternostro R, Jachs M, Hartl L, Semmler G, Hofer BS, Stättermayer AF, Pinter M, Lisman T, Trauner M, Quehenberger P, Reiberger T, Scheiner B, Mandorfer M. Platelet adhesion assessed by PFA-100 is not linked to progression of ACLD. Jhep Reports : Innovation in Hepatology. 6: 100934. PMID 38074505 DOI: 10.1016/j.jhepr.2023.100934 |
0.059 |
|
| 2017 |
Liu H, Naxerova K, Pinter M, Incio J, Lee H, Shigeta K, Ho WW, Crain JA, Jacobson A, Michelakos T, Dias-Santos D, Zanconato A, Hong TS, Clark JW, Murphy JE, et al. Use of Angiotensin System Inhibitors is Associated with Immune Activation and Longer Survival in Non-Metastatic Pancreatic Ductal Adenocarcinoma. Clinical Cancer Research : An Official Journal of the American Association For Cancer Research. PMID 28600474 DOI: 10.1158/1078-0432.Ccr-17-0256 |
0.059 |
|
| 2020 |
Saif M, Kwanten WJ, Carr JA, Chen IX, Posada JM, Srivastava A, Zhang J, Zheng Y, Pinter M, Chatterjee S, Softic S, Kahn CR, van Leyen K, Bruns OT, Jain RK, et al. Non-invasive monitoring of chronic liver disease via near-infrared and shortwave-infrared imaging of endogenous lipofuscin. Nature Biomedical Engineering. PMID 32572196 DOI: 10.1038/S41551-020-0569-Y |
0.058 |
|
| 2018 |
Rohr-Udilova N, Bauer E, Timelthaler G, Eferl R, Stolze K, Pinter M, Seif M, Hayden H, Reiberger T, Schulte-Hermann R, Peck-Radosavljevic M, Stoiber D, Trauner M. Impact of glutathione peroxidase 4 on cell proliferation, angiogenesis and cytokine production in hepatocellular carcinoma. Oncotarget. 9: 10054-10068. PMID 29515790 DOI: 10.18632/oncotarget.24300 |
0.058 |
|
| 2020 |
Chen IX, Newcomer K, Pauken KE, Juneja VR, Naxerova K, Wu MW, Pinter M, Sen DR, Singer M, Sharpe AH, Jain RK. A bilateral tumor model identifies transcriptional programs associated with patient response to immune checkpoint blockade. Proceedings of the National Academy of Sciences of the United States of America. PMID 32907939 DOI: 10.1073/Pnas.2002806117 |
0.058 |
|
| 2020 |
Spahn S, Roessler D, Pompilia R, Gabernet G, Gladstone BP, Horger M, Biskup S, Feldhahn M, Nahnsen S, Hilke FJ, Scheiner B, Dufour JF, De Toni EN, Pinter M, Malek NP, et al. Clinical and Genetic Tumor Characteristics of Responding and Non-Responding Patients to PD-1 Inhibition in Hepatocellular Carcinoma. Cancers. 12. PMID 33353145 DOI: 10.3390/cancers12123830 |
0.057 |
|
| 2024 |
Ajtai T, Utry N, Pintér M, Rahman A, Kurilla B, Sárossy G, Deák L, Baladincz J, Raffai P, Szabó G, Bozóki Z. The investigation of diesel soot emission using instrument combination of multi-wavelength photoacoustic spectroscopy and scanning mobility particle sizer. Scientific Reports. 14: 2254. PMID 38278878 DOI: 10.1038/s41598-024-52832-8 |
0.057 |
|
| 2022 |
Pinter M, Pinato DJ, Ramadori P, Heikenwalder M. NASH and hepatocellular carcinoma: immunology and immunotherapy. Clinical Cancer Research : An Official Journal of the American Association For Cancer Research. PMID 36166660 DOI: 10.1158/1078-0432.CCR-21-1258 |
0.056 |
|
| 2023 |
Simbrunner B, Villesen IF, Scheiner B, Paternostro R, Schwabl P, Stättermayer AF, Marculescu R, Pinter M, Quehenberger P, Trauner M, Karsdal M, Lisman T, Reiberger T, Leeming DJ, Mandorfer M. Von Willebrand factor processing in patients with advanced chronic liver disease and its relation to portal hypertension and clinical outcome. Hepatology International. PMID 37605068 DOI: 10.1007/s12072-023-10577-y |
0.056 |
|
| 2021 |
Pfister D, Núñez NG, Pinyol R, Govaere O, Pinter M, Szydlowska M, Gupta R, Qiu M, Deczkowska A, Weiner A, Müller F, Sinha A, Friebel E, Engleitner T, Lenggenhager D, et al. NASH limits anti-tumour surveillance in immunotherapy-treated HCC. Nature. PMID 33762733 DOI: 10.1038/s41586-021-03362-0 |
0.056 |
|
| 2020 |
Samadaei M, Pinter M, Senfter D, Madlener S, Rohr-Udilova N, Iwan D, Kamińska K, Wojaczyńska E, Wojaczyński J, Kochel A. Synthesis and Cytotoxic Activity of Chiral Sulfonamides Based on the 2-Azabicycloalkane Skeleton. Molecules (Basel, Switzerland). 25. PMID 32443610 DOI: 10.3390/molecules25102355 |
0.055 |
|
| 2022 |
Pomej K, Scheiner B, Balcar L, Nussbaumer RJ, Weinzierl J, Paternostro R, Simbrunner B, Bauer D, Pereyra D, Starlinger P, Stättermayer AF, Pinter M, Trauner M, Quehenberger P, Reiberger T, et al. Clinical significance of substantially elevated von Willebrand factor antigen levels in patients with advanced chronic liver disease. Digestive and Liver Disease : Official Journal of the Italian Society of Gastroenterology and the Italian Association For the Study of the Liver. PMID 35871985 DOI: 10.1016/j.dld.2022.06.010 |
0.055 |
|
| 2023 |
Macharia JM, Varjas T, Mwangi RW, Káposztás Z, Rozmann N, Pintér M, Wagara IN, Raposa BL. Modulatory Properties of Methanolic Extracts on Targeted Genes in Colorectal Cancer Management. Cancers. 15. PMID 37894369 DOI: 10.3390/cancers15205002 |
0.054 |
|
| 2023 |
Balcar L, Krawanja J, Scheiner B, Paternostro R, Simbrunner B, Semmler G, Jachs M, Hartl L, Stättermayer AF, Schwabl P, Pinter M, Szekeres T, Trauner M, Reiberger T, Mandorfer M. Impact of ammonia levels on outcome in clinically stable outpatients with advanced chronic liver disease. Jhep Reports : Innovation in Hepatology. 5: 100682. PMID 36873421 DOI: 10.1016/j.jhepr.2023.100682 |
0.053 |
|
| 2022 |
Himmelsbach V, Pinter M, Scheiner B, Venerito M, Sinner F, Zimpel C, Marquardt JU, Trojan J, Waidmann O, Finkelmeier F. Efficacy and Safety of Atezolizumab and Bevacizumab in the Real-World Treatment of Advanced Hepatocellular Carcinoma: Experience from Four Tertiary Centers. Cancers. 14. PMID 35406493 DOI: 10.3390/cancers14071722 |
0.051 |
|
| 2023 |
Celsa C, Cabibbo G, Am Fulgenzi C, Scheiner B, Manfredi GF, Nishida N, Ang C, Marron TU, Saeed A, Wietharn B, Pinter M, Cheon J, Huang YH, Lee PC, Phen S, et al. Characteristics and outcomes of immunotherapy-related liver injury in patients with hepatocellular carcinoma versus other advanced solid tumours. Journal of Hepatology. PMID 37972660 DOI: 10.1016/j.jhep.2023.10.040 |
0.051 |
|
| 2019 |
Iavarone M, Invernizzi F, Czauderna C, Sanduzzi-Zamparelli M, Bhoori S, Amaddeo G, Manini MA, Fraile López M, Anders M, Pinter M, Blanco Rodríguez MJ, Romero Cristóbal M, Aballay Soteras G, Piñero F, Villadsen GE, et al. Preliminary experience on safety of regorafenib after sorafenib failure in recurrent hepatocellular carcinoma after liver transplantation. American Journal of Transplantation : Official Journal of the American Society of Transplantation and the American Society of Transplant Surgeons. PMID 31365177 DOI: 10.1111/ajt.15551 |
0.051 |
|
| 2021 |
Semmler G, Binter T, Kozbial K, Schwabl P, Chromy D, Bauer D, Simbrunner B, Müllner-Bucsics T, Scheiner B, Stättermayer A, Pinter M, Steindl-Munda P, Trauner M, Ferenci P, Reiberger T, et al. Influence of Genetic Variants on Disease Regression and Outcomes in HCV-Related Advanced Chronic Liver Disease after SVR. Journal of Personalized Medicine. 11. PMID 33917196 DOI: 10.3390/jpm11040281 |
0.051 |
|
| 2022 |
Samadaei M, Senfter D, Madlener S, Uranowska K, Hafner C, Trauner M, Rohr-Udilova N, Pinter M. Targeting DNA repair to enhance the efficacy of sorafenib in hepatocellular carcinoma. Journal of Cellular Biochemistry. 123: 1663-1673. PMID 36271841 DOI: 10.1002/jcb.30340 |
0.051 |
|
| 2022 |
Sinner F, Pinter M, Scheiner B, Ettrich TJ, Sturm N, Gonzalez-Carmona MA, Waidmann O, Finkelmeier F, Himmelsbach V, De Toni EN, Ben Khaled N, Mohr R, Fründt TW, Kütting F, Bömmel FV, et al. Atezolizumab Plus Bevacizumab in Patients with Advanced and Progressing Hepatocellular Carcinoma: Retrospective Multicenter Experience. Cancers. 14. PMID 36497447 DOI: 10.3390/cancers14235966 |
0.05 |
|
| 2021 |
Paternostro R, Sieghart W, Trauner M, Pinter M. Cancer and hepatic steatosis. Esmo Open. 6: 100185. PMID 34139486 DOI: 10.1016/j.esmoop.2021.100185 |
0.05 |
|
| 2023 |
Dharmapuri S, Özbek U, Jethra H, Jun T, Marron TU, Saeed A, Huang YH, Muzaffar M, Pinter M, Balcar L, Fulgenzi C, Amara S, Weinmann A, Personeni N, Scheiner B, et al. Baseline neutrophil-lymphocyte ratio and platelet-lymphocyte ratio appear predictive of immune treatment related toxicity in hepatocellular carcinoma. World Journal of Gastrointestinal Oncology. 15: 1900-1912. PMID 38077640 DOI: 10.4251/wjgo.v15.i11.1900 |
0.049 |
|
| 2021 |
Uranowska K, Samadaei M, Kalic T, Pinter M, Breiteneder H, Hafner C. A chondroitin sulfate proteoglycan 4‑specific monoclonal antibody inhibits melanoma cell invasion in a spheroid model. International Journal of Oncology. 59. PMID 34318902 DOI: 10.3892/ijo.2021.5250 |
0.048 |
|
| 2022 |
Simbrunner B, Villesen IF, Königshofer P, Scheiner B, Bauer D, Paternostro R, Schwabl P, Timelthaler G, Ramazanova D, Wöran K, Stift J, Eigenbauer E, Stättermayer AF, Marculescu R, Pinter M, et al. Systemic inflammation is linked to liver fibrogenesis in patients with advanced chronic liver disease. Liver International : Official Journal of the International Association For the Study of the Liver. PMID 35822301 DOI: 10.1111/liv.15365 |
0.048 |
|
| 2008 |
Lechner E, Gitter R, Mair R, Pinter M, Schreier-Lechner E, Vondrys D, Tulzer G. Aminoterminal brain natriuretic peptide levels in children and adolescents after Fontan operation correlate with congestive heart failure. Pediatric Cardiology. 29: 901-5. PMID 18392788 DOI: 10.1007/s00246-008-9225-0 |
0.048 |
|
| 2018 |
Rohr-Udilova N, Klinglmüller F, Schulte-Hermann R, Stift J, Herac M, Salzmann M, Finotello F, Timelthaler G, Oberhuber G, Pinter M, Reiberger T, Jensen-Jarolim E, Eferl R, Trauner M. Deviations of the immune cell landscape between healthy liver and hepatocellular carcinoma. Scientific Reports. 8: 6220. PMID 29670256 DOI: 10.1038/s41598-018-24437-5 |
0.047 |
|
| 2022 |
Balcar L, Scheiner B, Urheu M, Weinberger P, Paternostro R, Simbrunner B, Hartl L, Jachs M, Bauer D, Semmler G, Willheim C, Pinter M, Ferenci P, Trauner M, Reiberger T, et al. Alpha-1 antitrypsin Pi∗Z allele is an independent risk factor for liver transplantation and death in patients with advanced chronic liver disease. Jhep Reports : Innovation in Hepatology. 4: 100562. PMID 36176936 DOI: 10.1016/j.jhepr.2022.100562 |
0.047 |
|
| 2008 |
Pinter M, Wichlas M, Schmid K, Plank C, Müller C, Wrba F, Peck-Radosavljevic M. Thalidomide in advanced hepatocellular carcinoma as antiangiogenic treatment approach: a phase I/II trial. European Journal of Gastroenterology & Hepatology. 20: 1012-9. PMID 18787470 DOI: 10.1097/MEG.0b013e3283036740 |
0.046 |
|
| 2021 |
Muhammed A, Fulgenzi CAM, Dharmapuri S, Pinter M, Balcar L, Scheiner B, Marron TU, Jun T, Saeed A, Hildebrand H, Muzaffar M, Navaid M, Naqash AR, Gampa A, Ozbek U, et al. The Systemic Inflammatory Response Identifies Patients with Adverse Clinical Outcome from Immunotherapy in Hepatocellular Carcinoma. Cancers. 14. PMID 35008350 DOI: 10.3390/cancers14010186 |
0.046 |
|
| 2021 |
Iwanejko J, Samadaei M, Pinter M, Senfter D, Madlener S, Kochel A, Rohr-Udilova N, Wojaczyńska E. Cytotoxic Activity of Piperazin-2-One-Based Structures: Cyclic Imines, Lactams, Aminophosphonates, and Their Derivatives. Materials (Basel, Switzerland). 14. PMID 33922317 DOI: 10.3390/ma14092138 |
0.046 |
|
| 2023 |
Zeng Q, Klein C, Caruso S, Maille P, Allende DS, Mínguez B, Iavarone M, Ningarhari M, Casadei-Gardini A, Pedica F, Rimini M, Perbellini R, Boulagnon-Rombi C, Heurgué A, Maggioni M, ... ... Pinter M, et al. Artificial intelligence-based pathology as a biomarker of sensitivity to atezolizumab-bevacizumab in patients with hepatocellular carcinoma: a multicentre retrospective study. The Lancet. Oncology. PMID 37951222 DOI: 10.1016/S1470-2045(23)00468-0 |
0.046 |
|
| 2017 |
Rohr-Udilova N, Klinglmüller F, Seif M, Hayden H, Bilban M, Pinter M, Stolze K, Sieghart W, Peck-Radosavljevic M, Trauner M. Oxidative stress mediates an increased formation of vascular endothelial growth factor in human hepatocarcinoma cells exposed to erlotinib. Oncotarget. 8: 57109-57120. PMID 28915658 DOI: 10.18632/oncotarget.19055 |
0.045 |
|
| 2013 |
Sieghart W, Hucke F, Pinter M, Graziadei I, Vogel W, Müller C, Heinzl H, Trauner M, Peck-Radosavljevic M. The ART of decision making: retreatment with transarterial chemoembolization in patients with hepatocellular carcinoma. Hepatology (Baltimore, Md.). 57: 2261-73. PMID 23316013 DOI: 10.1002/hep.26256 |
0.045 |
|
| 2021 |
Rohr-Udilova N, Tsuchiya K, Timelthaler G, Salzmann M, Meischl T, Wöran K, Stift J, Herac M, Schulte-Hermann R, Peck-Radosavljevic M, Sieghart W, Eferl R, Jensen-Jarolim E, Trauner M, Pinter M. Morphometric Analysis of Mast Cells in Tumor Predicts Recurrence of Hepatocellular Carcinoma After Liver Transplantation. Hepatology Communications. 5: 1939-1952. PMID 34558826 DOI: 10.1002/hep4.1770 |
0.045 |
|
| 2020 |
Meischl T, Rasoul-Rockenschaub S, Györi G, Scheiner B, Trauner M, Soliman T, Berlakovich G, Pinter M. Alpha-fetoprotein-adjusted-to-HCC-size criteria are associated with favourable survival after liver transplantation for hepatocellular carcinoma. United European Gastroenterology Journal. 2050640620948665. PMID 32741316 DOI: 10.1177/2050640620948665 |
0.045 |
|
| 2012 |
Reiberger T, Ulbrich G, Ferlitsch A, Payer BA, Schwabl P, Pinter M, Heinisch BB, Trauner M, Kramer L, Peck-Radosavljevic M. Carvedilol for primary prophylaxis of variceal bleeding in cirrhotic patients with haemodynamic non-response to propranolol. Gut. 62: 1634-41. PMID 23250049 DOI: 10.1136/gutjnl-2012-304038 |
0.044 |
|
| 2022 |
Scheiner B, Balcar L, Johanna Nussbaumer R, Weinzierl J, Paternostro R, Simbrunner B, Hartl L, Jachs M, Bauer D, Stättermayer AF, Semmler G, Pinter M, Ay C, Quehenberger P, Trauner M, et al. Factor VIII/protein C ratio independently predicts liver-related events but does not indicate a hypercoagulable state in ACLD. Journal of Hepatology. PMID 35066090 DOI: 10.1016/j.jhep.2021.12.038 |
0.044 |
|
| 2022 |
Macharia JM, Zhang L, Mwangi RW, Rozmann N, Kaposztas Z, Varjas T, Sugár M, Alfatafta H, Pintér M, Bence RL. Are chemical compounds in medical mushrooms potent against colorectal cancer carcinogenesis and antimicrobial growth? Cancer Cell International. 22: 379. PMID 36457023 DOI: 10.1186/s12935-022-02798-2 |
0.044 |
|
| 2020 |
Pomej K, Scheiner B, Park D, Bauer D, Balcar L, Meischl T, Mandorfer M, Reiberger T, Müller C, Trauner M, Pinter M. Vascular Complications in Patients with Hepatocellular Carcinoma Treated with Sorafenib. Cancers. 12. PMID 33066190 DOI: 10.3390/cancers12102961 |
0.044 |
|
| 2017 |
Pinter M, Jain RK. Targeting the renin-angiotensin system to improve cancer treatment: Implications for immunotherapy. Science Translational Medicine. 9. PMID 28978752 DOI: 10.1126/Scitranslmed.Aan5616 |
0.043 |
|
| 2019 |
Semmler G, Stift J, Scheiner B, Wöran K, Schwabl P, Paternostro R, Bucsics T, Stättermayer AF, Pinter M, Ferlitsch A, Trauner M, Reiberger T, Mandorfer M. Performance of Controlled Attenuation Parameter in Patients with Advanced Chronic Liver Disease and Portal Hypertension. Digestive Diseases and Sciences. 64: 3642-3651. PMID 31209721 DOI: 10.1007/s10620-019-05702-7 |
0.043 |
|
| 2023 |
Semmler G, Scheiner B, Balcar L, Paternostro R, Simbrunner B, Pinter M, Trauner M, Bofill Roig M, Meyer EL, Hofer BS, Mandorfer M, Pinato DJ, Zauner C, Reiberger T, Funk GC. Disturbances in sodium and chloride homeostasis predict outcome in stable and critically ill patients with cirrhosis. Alimentary Pharmacology & Therapeutics. PMID 37016513 DOI: 10.1111/apt.17507 |
0.042 |
|
| 1966 |
Pintér M, Bende I. [Septicemia and bacteremia caused by Alcaligenes faecalis]. Zeitschrift Fur Die Gesamte Innere Medizin Und Ihre Grenzgebiete. 20: 598-600. PMID 5866381 |
0.042 |
|
| 2020 |
Semmler G, Binter T, Kozbial K, Schwabl P, Hametner-Schreil S, Zanetto A, Gavasso S, Chromy D, Bauer DJM, Simbrunner B, Scheiner B, Bucsics T, Stättermayer AF, Pinter M, Steindl-Munda P, et al. Non-invasive risk stratification after HCV-eradication in patients with advanced chronic liver disease. Hepatology (Baltimore, Md.). PMID 32659847 DOI: 10.1002/hep.31462 |
0.042 |
|
| 2022 |
D'Alessio A, Fulgenzi CAM, Nishida N, Schönlein M, von Felden J, Schulze K, Wege H, Gaillard VE, Saeed A, Wietharn B, Hildebrand H, Wu L, Ang C, Marron TU, Weinmann A, ... ... Pinter M, et al. Preliminary evidence of safety and tolerability of atezolizumab plus bevacizumab in patients with hepatocellular carcinoma and Child-Pugh A and B cirrhosis: A real-world study. Hepatology (Baltimore, Md.). PMID 35313048 DOI: 10.1002/hep.32468 |
0.042 |
|
| 2022 |
Wu YL, Fulgenzi CAM, D'Alessio A, Cheon J, Nishida N, Saeed A, Wietharn B, Cammarota A, Pressiani T, Personeni N, Pinter M, Scheiner B, Balcar L, Huang YH, Phen S, et al. Neutrophil-to-Lymphocyte and Platelet-to-Lymphocyte Ratios as Prognostic Biomarkers in Unresectable Hepatocellular Carcinoma Treated with Atezolizumab plus Bevacizumab. Cancers. 14. PMID 36497316 DOI: 10.3390/cancers14235834 |
0.042 |
|
| 2023 |
Fulgenzi CAM, Scheiner B, Korolewicz J, Stikas CV, Gennari A, Vincenzi B, Openshaw MR, Silletta M, Pinter M, Cortellini A, Scotti L, D'Alessio A, Pinato DJ. Efficacy and safety of frontline systemic therapy for advanced HCC: A network meta-analysis of landmark phase III trials. Jhep Reports : Innovation in Hepatology. 5: 100702. PMID 37025943 DOI: 10.1016/j.jhepr.2023.100702 |
0.042 |
|
| 2023 |
Balcar L, Bauer D, Pomej K, Meischl T, Mandorfer M, Reiberger T, Trauner M, Scheiner B, Pinter M. Early changes in immunoglobulin G levels during immune checkpoint inhibitor treatment are associated with survival in hepatocellular carcinoma patients. Plos One. 18: e0282680. PMID 37027398 DOI: 10.1371/journal.pone.0282680 |
0.042 |
|
| 2020 |
Saif M, Kwanten WJ, Carr JA, Chen IX, Posada JM, Srivastava A, Zhang J, Zheng Y, Pinter M, Chatterjee S, Softic S, Kahn CR, van Leyen K, Bruns OT, Jain RK, et al. Author Correction: Non-invasive monitoring of chronic liver disease via near-infrared and shortwave-infrared imaging of endogenous lipofuscin. Nature Biomedical Engineering. PMID 33235308 DOI: 10.1038/s41551-020-00664-y |
0.041 |
|
| 1997 |
Hartyánszky IL, Pintér M, Kádár K, Oprea V, Krause I, Lozsádi K. Candida endocarditis in an infant. Pediatric Cardiology. 18: 440-2. PMID 9326693 DOI: 10.1007/s002469900225 |
0.041 |
|
| 2016 |
Pinter M, Trauner M, Peck-Radosavljevic M, Sieghart W. Cancer and liver cirrhosis: implications on prognosis and management. Esmo Open. 1: e000042. PMID 27843598 DOI: 10.1136/esmoopen-2016-000042 |
0.04 |
|
| 2020 |
Simbrunner B, Semmler G, Stadlmann A, Scheiner B, Schwabl P, Paternostro R, Bucsics T, Bauer D, Eigenbauer E, Pinter M, Stättermayer AF, Quehenberger P, Marculescu R, Trauner M, Mandorfer M, et al. Vitamin A levels reflect disease severity and portal hypertension in patients with cirrhosis. Hepatology International. PMID 33289910 DOI: 10.1007/s12072-020-10112-3 |
0.039 |
|
| 2018 |
Pinter M, Sieghart W. Long-term remission in advanced stage hepatocellular carcinoma? A chance for cure? Memo. 11: 185-192. PMID 30220924 DOI: 10.1007/s12254-018-0431-z |
0.039 |
|
| 1967 |
Pintér M. [Bacteriologic studies on the etiology of colpitis]. Geburtshilfe Und Frauenheilkunde. 26: 27-31. PMID 5982845 |
0.039 |
|
| 2022 |
Jachs M, Hartl L, Simbrunner B, Bauer D, Paternostro R, Scheiner B, Balcar L, Semmler G, Stättermayer AF, Pinter M, Quehenberger P, Trauner M, Reiberger T, Mandorfer M. The Sequential Application of Baveno VII Criteria and VITRO Score Improves Diagnosis of Clinically Significant Portal Hypertension. Clinical Gastroenterology and Hepatology : the Official Clinical Practice Journal of the American Gastroenterological Association. PMID 36244661 DOI: 10.1016/j.cgh.2022.09.032 |
0.039 |
|
| 2023 |
Balcar L, Scheiner B, Urheu M, Weinberger P, Paternostro R, Simbrunner B, Semmler G, Willheim C, Pinter M, Ferenci P, Trauner M, Reiberger T, Stättermayer AF, Mandorfer M. The impact of transmembrane 6 superfamily 2 (TM6SF2) rs58542926 on liver-related events in patients with advanced chronic liver disease. Digestive and Liver Disease : Official Journal of the Italian Society of Gastroenterology and the Italian Association For the Study of the Liver. PMID 36863929 DOI: 10.1016/j.dld.2023.02.012 |
0.039 |
|
| 2013 |
Sieghart W, Pinter M, Hucke F, Graziadei I, Schöniger-Hekele M, Müller C, Vogel W, Trauner M, Peck-Radosavljevic M. Single determination of C-reactive protein at the time of diagnosis predicts long-term outcome of patients with hepatocellular carcinoma. Hepatology (Baltimore, Md.). 57: 2224-34. PMID 22961713 DOI: 10.1002/hep.26057 |
0.039 |
|
| 2019 |
Stift J, Semmler G, Walzel C, Mandorfer M, Schwarzer R, Schwabl P, Paternostro R, Scheiner B, Wöran K, Pinter M, Stättermayer AF, Trauner M, Peck-Radosavljevic M, Ferlitsch A, Reiberger T. Transjugular aspiration liver biopsy performed by hepatologists trained in HVPG measurements is safe and provides important diagnostic information. Digestive and Liver Disease : Official Journal of the Italian Society of Gastroenterology and the Italian Association For the Study of the Liver. 51: 1144-1151. PMID 30862438 DOI: 10.1016/j.dld.2019.01.020 |
0.038 |
|
| 2021 |
Semmler G, Meyer EL, Kozbial K, Schwabl P, Hametner-Schreil S, Zanetto A, Bauer D, Chromy D, Simbrunner B, Scheiner B, Stättermayer AF, Pinter M, Schöfl R, Russo FP, Greenfield H, et al. HCC risk stratification after cure of hepatitis C in patients with compensated advanced chronic liver disease. Journal of Hepatology. PMID 34871626 DOI: 10.1016/j.jhep.2021.11.025 |
0.038 |
|
| 2021 |
Endmayr V, Tunc C, Ergin L, De Rosa A, Weng R, Wagner L, Yu TY, Fichtenbaum A, Perkmann T, Haslacher H, Kozakowski N, Schwaiger C, Ricken G, Hametner S, Klotz S, ... ... Pinter M, et al. Anti-Neuronal IgG4 Autoimmune Diseases and IgG4-Related Diseases May Not Be Part of the Same Spectrum: A Comparative Study. Frontiers in Immunology. 12: 785247. PMID 35095860 DOI: 10.3389/fimmu.2021.785247 |
0.038 |
|
| 2022 |
de Castro T, Jochheim LS, Bathon M, Welland S, Scheiner B, Shmanko K, Roessler D, Ben Khaled N, Jeschke M, Ludwig JM, Marquardt JU, Weinmann A, Pinter M, Lange CM, Vogel A, et al. Atezolizumab and bevacizumab in patients with advanced hepatocellular carcinoma with impaired liver function and prior systemic therapy: a real-world experience. Therapeutic Advances in Medical Oncology. 14: 17588359221080298. PMID 35251317 DOI: 10.1177/17588359221080298 |
0.037 |
|
| 2022 |
Jachs M, Hartl L, Simbrunner B, Bauer D, Paternostro R, Balcar L, Hofer B, Pfisterer N, Schwarz M, Scheiner B, Stättermayer AF, Pinter M, Trauner M, Mandorfer M, Reiberger T. Carvedilol achieves higher hemodynamic response and lower rebleeding rates than propranolol in secondary prophylaxis. Clinical Gastroenterology and Hepatology : the Official Clinical Practice Journal of the American Gastroenterological Association. PMID 35842118 DOI: 10.1016/j.cgh.2022.06.007 |
0.037 |
|
| 2005 |
Pintér M, Kolesárová M. [Genetic aspects of idiopatic inflammatory bowel disease]. Acta Medica (Hradec Kralove). Supplementum. 47: 83-7. PMID 16106737 |
0.037 |
|
| 1996 |
PINTER M, IVANYI J. CRITICAL PERIODS OF DEVELOPMENT. British Medical Journal. 1: 1569-70. PMID 14288123 DOI: 10.1136/bmj.1.5450.1569 |
0.037 |
|
| 2020 |
Pinter M, Jain RK, Duda DG. The Current Landscape of Immune Checkpoint Blockade in Hepatocellular Carcinoma: A Review. Jama Oncology. PMID 33090190 DOI: 10.1001/jamaoncol.2020.3381 |
0.037 |
|
| 2021 |
Pomej K, Scheiner B, Hartl L, Balcar L, Meischl T, Mandorfer M, Reiberger T, Müller C, Trauner M, Pinter M. COVID-19 pandemic: Impact on the management of patients with hepatocellular carcinoma at a tertiary care hospital. Plos One. 16: e0256544. PMID 34437610 DOI: 10.1371/journal.pone.0256544 |
0.037 |
|
| 2012 |
Sieghart W, Pinter M, Dauser B, Rohr-Udilova N, Piguet AC, Prager G, Hayden H, Dienes HP, Dufour JF, Peck-Radosavljevic M. Erlotinib and sorafenib in an orthotopic rat model of hepatocellular carcinoma. Journal of Hepatology. 57: 592-9. PMID 22634341 DOI: 10.1016/j.jhep.2012.04.034 |
0.036 |
|
| 2020 |
Simbrunner B, Stadlmann A, Schwabl P, Paternostro R, Bauer DJM, Bucsics T, Scheiner B, Lampichler K, Wöran K, Beer A, Eigenbauer E, Pinter M, Stättermayer AF, Marculescu R, Szekeres T, et al. Placental growth factor levels neither reflect severity of portal hypertension nor portal-hypertensive gastropathy in patients with advanced chronic liver disease. Digestive and Liver Disease : Official Journal of the Italian Society of Gastroenterology and the Italian Association For the Study of the Liver. PMID 33032973 DOI: 10.1016/j.dld.2020.09.006 |
0.036 |
|
| 2016 |
Reynolds SD, Rios C, Wesolowska-Andersen A, Zhuang Y, Pinter M, Happoldt C, Hill CL, Lallier SW, Cosgrove GP, Solomon GM, Nichols DP, Seibold MA. Airway Progenitor Clone Formation is Enhanced by Y-27632-dependent Changes in the Transcriptome. American Journal of Respiratory Cell and Molecular Biology. PMID 27144410 DOI: 10.1165/Rcmb.2015-0274Ma |
0.036 |
|
| 2020 |
Simbrunner B, Marculescu R, Scheiner B, Schwabl P, Bucsics T, Stadlmann A, Bauer D, Paternostro R, Eigenbauer E, Pinter M, Stättermayer AF, Trauner M, Mandorfer M, Reiberger T. Non-invasive detection of portal hypertension by enhanced liver fibrosis score in patients with different etiologies of advanced chronic liver disease. Liver International : Official Journal of the International Association For the Study of the Liver. PMID 32358998 DOI: 10.1111/liv.14498 |
0.036 |
|
| 2022 |
Talbot T, D'Alessio A, Pinter M, Balcar L, Scheiner B, Marron TU, Jun T, Dharmapuri S, Ang C, Saeed A, Hildebrand H, Muzaffar M, Fulgenzi CAM, Amara S, Naqash AR, et al. Progression patterns and therapeutic sequencing following immune checkpoint inhibition for HCC: an international observational study. Liver International : Official Journal of the International Association For the Study of the Liver. PMID 36577703 DOI: 10.1111/liv.15502 |
0.036 |
|
| 2018 |
Pinter M, Kwanten WJ, Jain RK. Renin-angiotensin system inhibitors to mitigate cancer treatment-related adverse events. Clinical Cancer Research : An Official Journal of the American Association For Cancer Research. PMID 29610292 DOI: 10.1158/1078-0432.Ccr-18-0236 |
0.036 |
|
| 2019 |
Schulte L, Scheiner B, Voigtländer T, Koch S, Schweitzer N, Marhenke S, Ivanyi P, Manns MP, Rodt T, Hinrichs JB, Weinmann A, Pinter M, Vogel A, Kirstein MM. Treatment with metformin is associated with a prolonged survival in patients with hepatocellular carcinoma. Liver International : Official Journal of the International Association For the Study of the Liver. PMID 30663219 DOI: 10.1111/liv.14048 |
0.036 |
|
| 2016 |
Incio J, Liu H, Suboj P, Chin SM, Chen IX, Pinter M, Ng MR, Nia HT, Grahovac J, Kao S, Babykutty S, Huang Y, Jung K, Rahbari NN, Han X, et al. Obesity-induced inflammation and desmoplasia promote pancreatic cancer progression and resistance to chemotherapy. Cancer Discovery. PMID 27246539 DOI: 10.1158/2159-8290.Cd-15-1177 |
0.036 |
|
| 2015 |
Pinter M, Ulbrich G, Sieghart W, Kölblinger C, Reiberger T, Li S, Ferlitsch A, Müller C, Lammer J, Peck-Radosavljevic M. Hepatocellular Carcinoma: A Phase II Randomized Controlled Double-Blind Trial of Transarterial Chemoembolization in Combination with Biweekly Intravenous Administration of Bevacizumab or a Placebo. Radiology. 142140. PMID 26131911 DOI: 10.1148/radiol.2015142140 |
0.036 |
|
| 2007 |
Lechner E, Moosbauer W, Pinter M, Mair R, Tulzer G. Use of levosimendan, a new inodilator, for postoperative myocardial stunning in a premature neonate. Pediatric Critical Care Medicine : a Journal of the Society of Critical Care Medicine and the World Federation of Pediatric Intensive and Critical Care Societies. 8: 61-3. PMID 17149153 DOI: 10.1097/01.PCC.0000253026.67341.5D |
0.036 |
|
| 2020 |
Stift J, Semmler G, Wöran K, Simbrunner B, Scheiner B, Schwabl P, Paternostro R, Pinter M, Stättermayer AF, Meischl T, Beer A, Trauner M, Mandorfer M, Reiberger T. Comparison of the diagnostic quality of aspiration and core-biopsy needles for transjugular liver biopsy. Digestive and Liver Disease : Official Journal of the Italian Society of Gastroenterology and the Italian Association For the Study of the Liver. 52: 1473-1479. PMID 32928675 DOI: 10.1016/j.dld.2020.08.028 |
0.035 |
|
| 2019 |
Semmler G, Simbrunner B, Scheiner B, Schwabl P, Paternostro R, Bucsics T, Staettermayer AF, Bauer D, Pinter M, Ferenci P, Trauner M, Mandorfer M, Reiberger T. Impact of farnesoid X receptor SNPs on hepatic decompensation and mortality in cirrhotic patients with portal hypertension. Journal of Gastroenterology and Hepatology. PMID 31062417 DOI: 10.1111/jgh.14700 |
0.035 |
|
| 2021 |
Pomej K, Balcar L, Scheiner B, Semmler G, Meischl T, Mandorfer M, Reiberger T, Müller C, Trauner M, Pinter M. Antibiotic Therapy is Associated with Worse Outcome in Patients with Hepatocellular Carcinoma Treated with Sorafenib. Journal of Hepatocellular Carcinoma. 8: 1485-1493. PMID 34877268 DOI: 10.2147/JHC.S317957 |
0.035 |
|
| 2021 |
Burghart L, Halilbasic E, Schwabl P, Simbrunner B, Stättermayer AF, Petrenko O, Scheiner B, Bauer D, Pinter M, Boztug K, Mandorfer M, Trauner M, Reiberger T. Distinct prognostic value of different portal hypertension-associated features in patients with primary biliary cholangitis. Journal of Gastroenterology. 57: 99-110. PMID 34893924 DOI: 10.1007/s00535-021-01839-3 |
0.035 |
|
| 2012 |
Pinter M, Sieghart W, Reiberger T, Rohr-Udilova N, Ferlitsch A, Peck-Radosavljevic M. The effects of sorafenib on the portal hypertensive syndrome in patients with liver cirrhosis and hepatocellular carcinoma--a pilot study. Alimentary Pharmacology & Therapeutics. 35: 83-91. PMID 22032637 DOI: 10.1111/j.1365-2036.2011.04896.x |
0.035 |
|
| 2015 |
Brainin M, Matz K, Nemec M, Teuschl Y, Dachenhausen A, Asenbaum-Nan S, Bancher C, Kepplinger B, Oberndorfer S, Pinter M, Schnider P, Tuomilehto J. Prevention of poststroke cognitive decline: ASPIS--a multicenter, randomized, observer-blind, parallel group clinical trial to evaluate multiple lifestyle interventions--study design and baseline characteristics. International Journal of Stroke : Official Journal of the International Stroke Society. 10: 627-35. PMID 24206541 DOI: 10.1111/ijs.12188 |
0.035 |
|
| 2020 |
Semmler G, Wöran K, Scheiner B, Unger LW, Paternostro R, Stift J, Schwabl P, Bucsics T, Bauer D, Simbrunner B, Stättermayer AF, Pinter M, Trauner M, Reiberger T, Mandorfer M. Novel reliability criteria for controlled attenuation parameter assessments for non-invasive evaluation of hepatic steatosis. United European Gastroenterology Journal. 8: 321-331. PMID 32213023 DOI: 10.1177/2050640619900820 |
0.035 |
|
| 2011 |
Sieghart W, Wang X, Schmid K, Pinter M, König F, Bodingbauer M, Wrba F, Rasoul-Rockenschaub S, Peck-Radosavljevic M. Osteopontin expression predicts overall survival after liver transplantation for hepatocellular carcinoma in patients beyond the Milan criteria. Journal of Hepatology. 54: 89-97. PMID 20970216 DOI: 10.1016/j.jhep.2010.06.030 |
0.035 |
|
| 2023 |
Wu YL, van Hyfte G, Özbek U, Reincke M, Gampa A, Mohamed YI, Nishida N, Wietharn B, Amara S, Lee PC, Scheiner B, Balcar L, Pinter M, Vogel A, Weinmann A, et al. Outcomes of beta blocker use in advanced hepatocellular carcinoma treated with immune checkpoint inhibitors. Frontiers in Oncology. 13: 1128569. PMID 36865801 DOI: 10.3389/fonc.2023.1128569 |
0.034 |
|
| 2023 |
Pinter M, Reig M, Cabibbo G. Analysis of individual patient data in patients with hepatocellular carcinoma treated with immunotherapy: A step forward for clinical trial design. Hepatology (Baltimore, Md.). PMID 37300382 DOI: 10.1097/HEP.0000000000000511 |
0.034 |
|
| 2022 |
Hucke F, Pinter M, Hucke M, Bota S, Bolf D, Hackl M, Peck-Radosavljevic M. Changing Epidemiological Trends of Hepatobiliary Carcinomas in Austria 2010-2018. Cancers. 14. PMID 35804861 DOI: 10.3390/cancers14133093 |
0.034 |
|
| 2022 |
Balcar L, Semmler G, Pomej K, Simbrunner B, Bauer D, Hartl L, Jachs M, Paternostro R, Bucsics T, Pinter M, Trauner M, Mandorfer M, Reiberger T, Scheiner B. Patterns of acute decompensation in hospitalized patients with cirrhosis and course of acute-on-chronic liver failure. United European Gastroenterology Journal. 9: 427-437. PMID 34050619 DOI: 10.1002/ueg2.12089 |
0.034 |
|
| 2017 |
Pinter M, Haupt L, Hucke F, Bota S, Bucsics T, Trauner M, Peck-Radosavljevic M, Sieghart W. The impact of thyroid hormones on patients with hepatocellular carcinoma. Plos One. 12: e0181878. PMID 28771610 DOI: 10.1371/journal.pone.0181878 |
0.034 |
|
| 2021 |
Iavarone M, Invernizzi F, Ivanics T, Mazza S, Zavaglia C, Sanduzzi-Zamparelli M, Fraile-López M, Czauderna C, Di Costanzo G, Bhoori S, Pinter M, Manini MA, Amaddeo G, Yunquera AF, Piñero F, et al. Regorafenib efficacy after sorafenib in patients with recurrent HCC after liver transplantation: a retrospective study. Liver Transplantation : Official Publication of the American Association For the Study of Liver Diseases and the International Liver Transplantation Society. PMID 34388851 DOI: 10.1002/lt.26264 |
0.034 |
|
| 2024 |
Jachs M, Hartl L, Simbrunner B, Semmler G, Balcar L, Hofer BS, Schwarz M, Bauer D, Stättermayer AF, Pinter M, Trauner M, Reiberger T, Mandorfer M. Prognostic performance of non-invasive tests for portal hypertension is comparable to that of hepatic venous pressure gradient. Journal of Hepatology. PMID 38218352 DOI: 10.1016/j.jhep.2023.12.028 |
0.033 |
|
| 2005 |
Silverman J, Garnett NL, Giszter SF, Heckman CJ, Kulpa-Eddy JA, Lemay MA, Perry CK, Pinter M. Decerebrate mammalian preparations: unalleviated or fully alleviated pain? A review and opinion. Contemporary Topics in Laboratory Animal Science / American Association For Laboratory Animal Science. 44: 34-6. PMID 16050666 |
0.033 |
|
| 2020 |
Díaz-González Á, Sanduzzi-Zamparelli M, Gomes da Fonseca LL, Di Costanzo GG, Alves R, Iavarone M, Leal C, Sacco R, Matilla AM, Hernández-Guerra M, Aballay Soteras G, Wörns MA, Pinter M, Varela M, Ladekarl M, et al. International and multicenter real-world study of sorafenib-treated patients with hepatocellular carcinoma under dialysis. Liver International : Official Journal of the International Association For the Study of the Liver. PMID 32170821 DOI: 10.1111/liv.14436 |
0.033 |
|
| 2006 |
Bures J, Kopácová M, Koupil I, Vorísek V, Rejchrt S, Beránek M, Seifert B, Pozler O, Zivný P, Douda T, Kolesárová M, Pintér M, Palicka V, Holcík J. Epidemiology of Helicobacter pylori infection in the Czech Republic. Helicobacter. 11: 56-65. PMID 16423091 DOI: 10.1111/j.0083-8703.2006.00369.x |
0.033 |
|
| 2012 |
Reiberger T, Ferlitsch A, Payer BA, Pinter M, Schwabl P, Stift J, Trauner M, Peck-Radosavljevic M. Noninvasive screening for liver fibrosis and portal hypertension by transient elastography--a large single center experience. Wiener Klinische Wochenschrift. 124: 395-402. PMID 22699260 DOI: 10.1007/s00508-012-0190-5 |
0.033 |
|
| 2012 |
Brainin M, Pinter M. Poststroke fatigue: a hint, but no definite word on therapy yet. Stroke. 43: 933-4. PMID 22308245 DOI: 10.1161/STROKEAHA.111.644856 |
0.033 |
|
| 2018 |
Incio J, Ligibel JA, McManus DT, Suboj P, Jung K, Kawaguchi K, Pinter M, Babykutty S, Chin SM, Vardam TD, Huang Y, Rahbari NN, Roberge S, Wang D, Gomes-Santos IL, et al. Obesity promotes resistance to anti-VEGF therapy in breast cancer by up-regulating IL-6 and potentially FGF-2. Science Translational Medicine. 10. PMID 29540614 DOI: 10.1126/Scitranslmed.Aag0945 |
0.033 |
|
| 2019 |
Mandorfer M, Kozbial K, Schwabl P, Chromy D, Semmler G, Stättermayer AF, Pinter M, Hernández-Gea V, Fritzer-Szekeres M, Steindl-Munda P, Trauner M, Peck-Radosavljevic M, García-Pagán JC, Ferenci P, Reiberger T. Changes in Hepatic Venous Pressure Gradient Predict Hepatic Decompensation in Patients Who Achieved Sustained Virologic Response to Interferon-Free Therapy. Hepatology (Baltimore, Md.). 71: 1023-1036. PMID 31365764 DOI: 10.1002/hep.30885 |
0.033 |
|
| 2023 |
Breitenecker K, Hedrich V, Pupp F, Chen D, Řezníčková E, Ortmayr G, Huber H, Weber G, Balcar L, Pinter M, Mikulits W. Synergism of the receptor tyrosine kinase Axl with ErbB receptors mediates resistance to regorafenib in hepatocellular carcinoma. Frontiers in Oncology. 13: 1238883. PMID 37746265 DOI: 10.3389/fonc.2023.1238883 |
0.033 |
|
| 2022 |
Macharia JM, Gakenye GW, Rozmann N, Onchonga D, Mwangi RW, Kaposztas Z, Mathenge JM, Pusztai D, Pinter M, Sugar M, Raposa BL. An empirical assessment of the factors influencing acceptance of COVID-19 vaccine uptake between Kenyan and Hungarian residing populations: A cross-sectional study. Scientific Reports. 12: 22262. PMID 36564451 DOI: 10.1038/s41598-022-26824-5 |
0.032 |
|
| 2020 |
Jachs M, Hartl L, Schaufler D, Desbalmes C, Simbrunner B, Eigenbauer E, Bauer DJM, Paternostro R, Schwabl P, Scheiner B, Bucsics T, Stättermayer AF, Pinter M, Trauner M, Mandorfer M, et al. Amelioration of systemic inflammation in advanced chronic liver disease upon beta-blocker therapy translates into improved clinical outcomes. Gut. PMID 33199442 DOI: 10.1136/gutjnl-2020-322712 |
0.032 |
|
| 2019 |
Meischl T, Rasoul-Rockenschaub S, Györi G, Sieghart W, Reiberger T, Trauner M, Soliman T, Berlakovich G, Pinter M. C-reactive protein is an independent predictor for hepatocellular carcinoma recurrence after liver transplantation. Plos One. 14: e0216677. PMID 31141535 DOI: 10.1371/journal.pone.0216677 |
0.031 |
|
| 2024 |
Dominik N, Scheiner B, Zanetto A, Balcar L, Semmler G, Campello E, Schwarz M, Paternostro R, Simbrunner B, Hofer BS, Stättermayer AF, Pinter M, Trauner M, Quehenberger P, Simioni P, et al. Von Willebrand factor for outcome prediction within different clinical stages of advanced chronic liver disease. Alimentary Pharmacology & Therapeutics. PMID 38482706 DOI: 10.1111/apt.17945 |
0.031 |
|
| 2023 |
Balcar L, Scheiner B, Fulgenzi CAM, D'Alessio A, Pomej K, Roig MB, Meyer EL, Che J, Nishida N, Lee PC, Wu L, Ang C, Krall A, Saeed A, Stefanini B, ... ... Pinter M, et al. A meta-analysis and real-world cohort study on the sex-related differences in efficacy and safety of immunotherapy for hepatocellular carcinoma. Jhep Reports : Innovation in Hepatology. 6: 100982. PMID 38274490 DOI: 10.1016/j.jhepr.2023.100982 |
0.03 |
|
| 2024 |
Balcar L, Mrekva A, Scheiner B, Pomej K, Meischl T, Mandorfer M, Reiberger T, Trauner M, Tamandl D, Pinter M. Management of varices but not anticoagulation is associated with improved outcome in patients with HCC and macrovascular tumour invasion. Cancer Imaging : the Official Publication of the International Cancer Imaging Society. 24: 9. PMID 38217049 DOI: 10.1186/s40644-024-00657-z |
0.03 |
|
| 2020 |
Costa D, Simbrunner B, Jachs M, Hartl L, Bauer D, Paternostro R, Schwabl P, Scheiner B, StÄttermayer AF, Pinter M, Trauner M, Mandorfer M, Reiberger T. Systemic inflammation increases across distinct stages of advanced chronic liver disease and correlates with decompensation and mortality. Journal of Hepatology. PMID 33075344 DOI: 10.1016/j.jhep.2020.10.004 |
0.03 |
|
| 2021 |
Semmler G, Pomej K, Bauer DJM, Balcar L, Simbrunner B, Binter T, Hartl L, Becker J, Pinter M, Quehenberger P, Trauner M, Mandorfer M, Lisman T, Reiberger T, Scheiner B. Safety of direct oral anticoagulants (DOACs) in patients with advanced liver disease. Liver International : Official Journal of the International Association For the Study of the Liver. PMID 34152697 DOI: 10.1111/liv.14992 |
0.029 |
|
| 2022 |
Vithayathil M, D'Alessio A, Fulgenzi CAM, Nishida N, Schönlein M, von Felden J, Schulze K, Wege H, Saeed A, Wietharn B, Hildebrand H, Wu L, Ang C, Marron TU, Weinmann A, ... ... Pinter M, et al. Impact of older age in patients receiving atezolizumab and bevacizumab for hepatocellular carcinoma. Liver International : Official Journal of the International Association For the Study of the Liver. 42: 2538-2547. PMID 35986902 DOI: 10.1111/liv.15405 |
0.029 |
|
| 2002 |
ABRAHAM E, PINTER M, RAVNAY M. Studies on the occurrence of poliomyelitis viruses in Hungary. Acta Microbiologica Academiae Scientiarum Hungaricae. 3: 399-403. PMID 13354310 |
0.028 |
|
| 2023 |
Pinter M, Scheiner B, Pinato DJ. Immune checkpoint inhibitors in hepatocellular carcinoma: emerging challenges in clinical practice. The Lancet. Gastroenterology & Hepatology. 8: 760-770. PMID 37327807 DOI: 10.1016/S2468-1253(23)00147-4 |
0.027 |
|
| 2024 |
Dekervel J, Casadei-Gardini A, Pinter M. Controversies in upper GI oncology: first-line systemic treatment in MASLD-associated HCC. Esmo Open. 9: 102245. PMID 38335903 DOI: 10.1016/j.esmoop.2024.102245 |
0.027 |
|
| 2004 |
Elmadfa I, Rust P, Majchrzak D, Wagner KH, Genser D, Lettner R, Pinter M. Effects of beta-carotene supplementation on free radical mechanism in healthy adult subjects International Journal For Vitamin and Nutrition Research. 74: 147-152. PMID 15255452 DOI: 10.1024/0300-9831.74.2.147 |
0.027 |
|
| 2019 |
Sprinzl MF, Kirstein MM, Koch S, Seib ML, Weinmann-Menke J, Lang H, Düber C, Toenges G, Zöller D, Marquardt JU, Wörns MA, Galle PR, Vogel A, Pinter M, Weinmann A. Improved Prediction of Survival by a Risk Factor-Integrating Inflammatory Score in Sorafenib-Treated Hepatocellular Carcinoma. Liver Cancer. 8: 387-402. PMID 31768347 DOI: 10.1159/000492628 |
0.027 |
|
| 2014 |
Hucke F, Sieghart W, Pinter M, Graziadei I, Vogel W, Müller C, Heinzl H, Waneck F, Trauner M, Peck-Radosavljevic M. The ART-strategy: sequential assessment of the ART score predicts outcome of patients with hepatocellular carcinoma re-treated with TACE. Journal of Hepatology. 60: 118-26. PMID 24012941 DOI: 10.1016/j.jhep.2013.08.022 |
0.027 |
|
| 2014 |
Pinter M, Hucke F, Zielonke N, Trauner M, Sieghart W, Peck-Radosavljevic M. Epidemiological trends of hepatocellular carcinoma in Austria. Digestive Diseases (Basel, Switzerland). 32: 664-9. PMID 25376282 DOI: 10.1159/000367983 |
0.027 |
|
| 2003 |
PINTER M. [Experimental poliomyelitis, studies in Hungary]. Orvosi Hetilap. 93: 517-21. PMID 13003273 |
0.027 |
|
| 2023 |
Xie E, Yeo YH, Scheiner B, Zhang Y, Hiraoka A, Tantai X, Fessas P, de Castro T, D'Alessio A, Fulgenzi CAM, Xu S, Tsai HM, Kambhampati S, Wang W, Keenan BP, ... ... Pinter M, et al. Immune Checkpoint Inhibitors for Child-Pugh Class B Advanced Hepatocellular Carcinoma: A Systematic Review and Meta-Analysis. Jama Oncology. PMID 37615958 DOI: 10.1001/jamaoncol.2023.3284 |
0.026 |
|
| 2021 |
Fessas P, Naeem M, Pinter M, Marron TU, Szafron D, Balcar L, Saeed A, Jun T, Dharmapuri S, Gampa A, Wang Y, Khan U, Muzaffar M, Navaid M, Lee PC, et al. Early Antibiotic Exposure Is Not Detrimental to Therapeutic Effect from Immunotherapy in Hepatocellular Carcinoma. Liver Cancer. 10: 583-592. PMID 34950181 DOI: 10.1159/000519108 |
0.026 |
|
| 2017 |
Pinter M, Weinmann A, Wörns MA, Hucke F, Bota S, Marquardt JU, Duda DG, Jain RK, Galle PR, Trauner M, Peck-Radosavljevic M, Sieghart W. Use of inhibitors of the renin-angiotensin system is associated with longer survival in patients with hepatocellular carcinoma. United European Gastroenterology Journal. 5: 987-996. PMID 29163965 DOI: 10.1177/2050640617695698 |
0.026 |
|
| 2021 |
Hartl L, Semmler G, Hofer BS, Schirwani N, Jachs M, Simbrunner B, Bauer DJM, Binter T, Pomej K, Pinter M, Trauner M, Mandorfer M, Reiberger T, Scheiner B. COVID-19-related downscaling of in-hospital liver care decreased patient satisfaction and increased liver-related mortality. Hepatology Communications. PMID 34222742 DOI: 10.1002/hep4.1758 |
0.026 |
|
| 2023 |
Vithayathil M, D'Alessio A, Fulgenzi CAM, Nishida N, Schönlein M, von Felden J, Schulze K, Wege H, Saeed A, Wietharn B, Hildebrand H, Wu L, Ang C, Marron TU, Weinmann A, ... ... Pinter M, et al. Impact of body mass index in patients receiving atezolizumab plus bevacizumab for hepatocellular carcinoma. Hepatology International. PMID 37005953 DOI: 10.1007/s12072-023-10491-3 |
0.026 |
|
| 2009 |
Pinter M, Sieghart W, Graziadei I, Vogel W, Maieron A, Königsberg R, Weissmann A, Kornek G, Plank C, Peck-Radosavljevic M. Sorafenib in unresectable hepatocellular carcinoma from mild to advanced stage liver cirrhosis. The Oncologist. 14: 70-6. PMID 19144684 DOI: 10.1634/theoncologist.2008-0191 |
0.026 |
|
| 2019 |
Scheiner B, Pinter M. Response to the Letter to the Editor Concerning the Publication "Association of Platelet Count and Mean Platelet Volume with Overall Survival in Patients with Cirrhosis and Unresectable Hepatocellular Carcinoma". Liver Cancer. 9: 107. PMID 32071915 DOI: 10.1159/000502745 |
0.026 |
|
| 2019 |
Scheiner B, Kirstein M, Popp S, Hucke F, Bota S, Rohr-Udilova N, Reiberger T, Müller C, Trauner M, Peck-Radosavljevic M, Vogel A, Sieghart W, Pinter M. Association of Platelet Count and Mean Platelet Volume with Overall Survival in Patients with Cirrhosis and Unresectable Hepatocellular Carcinoma. Liver Cancer. 8: 203-217. PMID 31192156 DOI: 10.1159/000489833 |
0.026 |
|
| 2020 |
Scheiner B, Stättermayer AF, Schwabl P, Bucsics T, Paternostro R, Bauer D, Simbrunner B, Schmidt R, Marculescu R, Ferlitsch A, Peck-Radosavljevic M, Pinter M, Trauner M, Reiberger T, Ferenci P, et al. Impact of HSD17B13 rs72613567 genotype on hepatic decompensation and mortality in patients with portal hypertension. Liver International : Official Journal of the International Association For the Study of the Liver. 40: 393-404. PMID 31967400 DOI: 10.1111/liv.14304 |
0.025 |
|
| 1972 |
Csillag Z, Makkai F, Pintér M. [Experimental studies on fillings sealed with Diaket]. Fogorvosi Szemle. 65: 265-9. PMID 4505974 |
0.025 |
|
| 2023 |
Pinato DJ, Li X, Mishra-Kalyani P, D'Alessio A, Fulgenzi CAM, Scheiner B, Pinter M, Wei G, Schneider J, Rivera DR, Pazdur R, Theoret MR, Casak S, Lemery S, Fashoyin-Aje L, et al. Association between antibiotics and adverse oncological outcomes in patients receiving targeted or immune-based therapy for hepatocellular carcinoma. Jhep Reports : Innovation in Hepatology. 5: 100747. PMID 37197442 DOI: 10.1016/j.jhepr.2023.100747 |
0.024 |
|
| 2020 |
Simbrunner B, Beer A, Wöran K, Schmitz F, Primas C, Wewalka M, Pinter M, Dolak W, Scheiner B, Puespoek A, Trauner M, Oberhuber G, Mandorfer M, Reiberger T. Portal hypertensive gastropathy is associated with iron deficiency anemia. Wiener Klinische Wochenschrift. 132: 1-11. PMID 31912289 DOI: 10.1007/s00508-019-01593-w |
0.024 |
|
| 2022 |
Fulgenzi CAM, Cheon J, D'Alessio A, Nishida N, Ang C, Marron TU, Wu L, Saeed A, Wietharn B, Cammarota A, Pressiani T, Personeni N, Pinter M, Scheiner B, Balcar L, et al. Reproducible safety and efficacy of atezolizumab plus bevacizumab for HCC in clinical practice: Results of the AB-real study. European Journal of Cancer (Oxford, England : 1990). 175: 204-213. PMID 36148739 DOI: 10.1016/j.ejca.2022.08.024 |
0.024 |
|
| 2014 |
Hucke F, Pinter M, Graziadei I, Bota S, Vogel W, Müller C, Heinzl H, Waneck F, Trauner M, Peck-Radosavljevic M, Sieghart W. How to STATE suitability and START transarterial chemoembolization in patients with intermediate stage hepatocellular carcinoma. Journal of Hepatology. 61: 1287-96. PMID 25016222 DOI: 10.1016/j.jhep.2014.07.002 |
0.023 |
|
| 2005 |
Kolesárová M, Pintér M. [The influence of fertility and idiopatic bowel disease: a summary]. Acta Medica (Hradec Kralove). Supplementum. 47: 89-96. PMID 16106738 |
0.023 |
|
| 2004 |
KOCH S, PINTER M, IVANOVICS G. [Etiologic and epidemic significance of lymphocytic choriomeningitis virus in Hungary]. Orvosi Hetilap. 91: 865-71. PMID 14827542 |
0.023 |
|
| 2021 |
Scheiner B, Pomej K, Kirstein MM, Hucke F, Finkelmeier F, Waidmann O, Himmelsbach V, Schulze K, von Felden J, Fründt TW, Stadler M, Heinzl H, Shmanko K, Spahn S, Radu P, ... ... Pinter M, et al. Prognosis of patients with hepatocellular carcinoma treated with immunotherapy - development and validation of the CRAFITY score. Journal of Hepatology. PMID 34648895 DOI: 10.1016/j.jhep.2021.09.035 |
0.023 |
|
| 2023 |
Joerg V, Scheiner B, D Alessio A, Fulgenzi CAM, Schönlein M, Kocheise L, Lohse AW, Huber S, Wege H, Kaseb A, Wang Y, Mathew A, Kuang A, Muzaffar M, Abugabal YI, ... ... Pinter M, et al. Efficacy and safety of atezolizumab/bevacizumab in patients with HCC after prior systemic therapy: A global, observational study. Hepatology Communications. 7. PMID 37889520 DOI: 10.1097/HC9.0000000000000302 |
0.022 |
|
| 2007 |
Pintér M, Pintérová KM, Drahosová M, Rejchrt S, Douda T, Tachecí I, Kopácová M, Bures J. [Significance of serum antibodies ANCA, ASCA, ABBA in diagnostics of idiopathic intestinal inflammations]. CasopíS LéKar̆ů C̆EskýCh. 146: 863-7. PMID 18069213 |
0.022 |
|
| 2019 |
Scheiner B, Ulbrich G, Mandorfer M, Reiberger T, Müller C, Waneck F, Trauner M, Kölblinger C, Ferlitsch A, Sieghart W, Peck-Radosavljevic M, Pinter M. Short- and long-term effects of transarterial chemoembolization on portal hypertension in patients with hepatocellular carcinoma. United European Gastroenterology Journal. 7: 850-858. PMID 31316789 DOI: 10.1177/2050640619840199 |
0.022 |
|
| 2011 |
Pinter M, Sieghart W, Hucke F, Graziadei I, Vogel W, Maieron A, Königsberg R, Weissmann A, Kornek G, Matejka J, Stauber R, Buder R, Grünberger B, Schöniger-Hekele M, Müller C, et al. Prognostic factors in patients with advanced hepatocellular carcinoma treated with sorafenib. Alimentary Pharmacology & Therapeutics. 34: 949-59. PMID 21883324 DOI: 10.1111/j.1365-2036.2011.04823.x |
0.022 |
|
| 2022 |
Scheiner B, Pinter M. Reply to: "The CRAFITY score: A new guidepost for prognosis prediction in patients with hepatocellular carcinoma undergoing immunotherapy". Journal of Hepatology. 76: 1233-1234. PMID 35176440 DOI: 10.1016/j.jhep.2022.02.002 |
0.022 |
|
| 2020 |
Kirstein MM, Scheiner B, Marwede T, Wolf C, Voigtländer T, Semmler G, Wacker F, Manns MP, Hinrichs JB, Pinter M, Vogel A. Sequential systemic treatment in patients with hepatocellular carcinoma. Alimentary Pharmacology & Therapeutics. PMID 32432799 DOI: 10.1111/apt.15789 |
0.021 |
|
| 2012 |
Sieghart W, Pinter M, Reisegger M, Müller C, Ba-Ssalamah A, Lammer J, Peck-Radosavljevic M. Conventional transarterial chemoembolisation in combination with sorafenib for patients with hepatocellular carcinoma: a pilot study. European Radiology. 22: 1214-23. PMID 22215073 DOI: 10.1007/s00330-011-2368-z |
0.021 |
|
| 1993 |
Nowycky MC, Pinter MJ. Time courses of calcium and calcium-bound buffers following calcium influx in a model cell. Biophysical Journal. 64: 77-91. PMID 8431551 DOI: 10.1016/S0006-3495(93)81342-0 |
0.02 |
|
| 2003 |
BALAZS V, PINTER M. Studies on Coxsackie virus infection in Hungary. II. Studies on neutralising antibodies against fourteen different types of Coxsackie virus in individual and pooled human sera. Acta Microbiologica Academiae Scientiarum Hungaricae. 2: 429-33. PMID 13248483 |
0.02 |
|
| 2009 |
Pintér M, Pintérová Kolesárová M, Rejchrt S, Douda T, Repák R, Kopáová M, Bures J. [Inflammatory bowel disease--familial and sporadic form]. Vnitr̆Ní LéKar̆Ství. 55: 1022-9. PMID 20017432 |
0.02 |
|
| 2022 |
Pinter M, Pinato DJ. Local and systemic therapy in liver cancer: the quest for synergy. The Lancet. Gastroenterology & Hepatology. 8: 102-104. PMID 36529151 DOI: 10.1016/S2468-1253(22)00350-8 |
0.019 |
|
| 2018 |
Pinter M, Peck-Radosavljevic M. Review article: systemic treatment of hepatocellular carcinoma. Alimentary Pharmacology & Therapeutics. 48: 598-609. PMID 30039640 DOI: 10.1111/apt.14913 |
0.019 |
|
| 2022 |
Scheiner B, Roessler D, Phen S, Lim M, Pomej K, Pressiani T, Cammarota A, Fründt TW, von Felden J, Schulze K, Himmelsbach V, Finkelmeier F, Deibel A, Siebenhüner AR, Shmanko K, ... ... Pinter M, et al. Efficacy and safety of immune checkpoint inhibitor rechallenge in individuals with hepatocellular carcinoma. Jhep Reports : Innovation in Hepatology. 5: 100620. PMID 36578451 DOI: 10.1016/j.jhepr.2022.100620 |
0.019 |
|
| 2008 |
Rejchrt S, Drahosová M, Kopácová M, Cyrany J, Douda T, Pintér M, Bures J. Antilaminaribioside and antichitobioside antibodies in inflammatory bowel disease. Folia Microbiologica. 53: 373-6. PMID 18759124 DOI: 10.1007/s12223-008-0058-2 |
0.019 |
|
| 2000 |
PINTER M. [New results in virus research achieved with the aid of tissue culturing]. Orvosi Hetilap. 99: 217-24. PMID 13542027 |
0.019 |
|
| 2021 |
Scheiner B, Pinter M. Reply to: "Prognostic prediction for patients with hepatocellular carcinoma receiving immunotherapy: Are we there yet?". Journal of Hepatology. 76: 988-989. PMID 34979133 DOI: 10.1016/j.jhep.2021.12.025 |
0.019 |
|
| 2014 |
Caldovic L, Haskins N, Mumo A, Majumdar H, Pinter M, Tuchman M, Krufka A. Expression pattern and biochemical properties of zebrafish N-acetylglutamate synthase. Plos One. 9: e85597. PMID 24465614 DOI: 10.1371/journal.pone.0085597 |
0.019 |
|
| 2023 |
Pomej K, Balcar L, Shmanko K, Welland S, Himmelsbach V, Scheiner B, Mahyera A, Mozayani B, Trauner M, Finkelmeier F, Weinmann A, Vogel A, Pinter M. Clinical characteristics and outcome of patients with combined hepatocellular-cholangiocarcinoma-a European multicenter cohort. Esmo Open. 8: 100783. PMID 36753993 DOI: 10.1016/j.esmoop.2023.100783 |
0.018 |
|
| 2012 |
Pinter M, Hucke F, Graziadei I, Vogel W, Maieron A, Königsberg R, Stauber R, Grünberger B, Müller C, Kölblinger C, Peck-Radosavljevic M, Sieghart W. Advanced-stage hepatocellular carcinoma: transarterial chemoembolization versus sorafenib. Radiology. 263: 590-9. PMID 22438359 DOI: 10.1148/radiol.12111550 |
0.018 |
|
| 1996 |
PINTER M, IVANYI J. KEEPING THE HEART GOING. British Medical Journal. 1: 1566-7. PMID 14288119 DOI: 10.1136/bmj.1.5450.1566 |
0.017 |
|
| 2011 |
Reiberger T, Ferlitsch A, Payer BA, Pinter M, Homoncik M, Peck-Radosavljevic M. Non-selective β-blockers improve the correlation of liver stiffness and portal pressure in advanced cirrhosis. Journal of Gastroenterology. 47: 561-8. PMID 22170417 DOI: 10.1007/s00535-011-0517-4 |
0.017 |
|
| 2014 |
Pinter M, Hucke F, Zielonke N, Waldhör T, Trauner M, Peck-Radosavljevic M, Sieghart W. Incidence and mortality trends for biliary tract cancers in Austria. Liver International : Official Journal of the International Association For the Study of the Liver. 34: 1102-8. PMID 24119058 DOI: 10.1111/liv.12325 |
0.017 |
|
| 2013 |
Pinter M, Sieghart W, Schmid M, Dauser B, Prager G, Dienes HP, Trauner M, Peck-Radosavljevic M. Hedgehog inhibition reduces angiogenesis by downregulation of tumoral VEGF-A expression in hepatocellular carcinoma. United European Gastroenterology Journal. 1: 265-75. PMID 24917971 DOI: 10.1177/2050640613496605 |
0.017 |
|
| 2020 |
Kirstein MM, Scheiner B, Pinter M, Vogel A. Letter: sequential or combined systemic treatment for unresectable hepatocellular carcinoma-authors' reply. Alimentary Pharmacology & Therapeutics. 52: 917-918. PMID 32852807 DOI: 10.1111/apt.15980 |
0.016 |
|
| 2003 |
PINTER M, ABRAHAM E, RAVNAY M. [Isolation experiments and serological studies with poliomyelitis virus in tissue culture]. Orvosi Hetilap. 97: 393-7. PMID 13335208 |
0.016 |
|
| 2017 |
Li S, Peck-Radosavljevic M, Ubl P, Wadsak W, Mitterhauser M, Rainer E, Pinter M, Wang H, Nanoff C, Kaczirek K, Haug A, Hacker M. The value of [(11)C]-acetate PET and [(18)F]-FDG PET in hepatocellular carcinoma before and after treatment with transarterial chemoembolization and bevacizumab. European Journal of Nuclear Medicine and Molecular Imaging. PMID 28555333 DOI: 10.1007/s00259-017-3724-2 |
0.016 |
|
| 2021 |
Finkelmeier F, Scheiner B, Leyh C, Best J, Fründt TW, Czauderna C, Beutel A, Bettinger D, Weiß J, Meischl T, Kütting F, Waldschmidt DT, Radu P, Schultheiß M, Peiffer KH, ... ... Pinter M, et al. Cabozantinib in Advanced Hepatocellular Carcinoma: Efficacy and Safety Data from an International Multicenter Real-Life Cohort. Liver Cancer. 10: 360-369. PMID 34414123 DOI: 10.1159/000515490 |
0.015 |
|
| 2019 |
Scheiner B, Kirstein MM, Hucke F, Finkelmeier F, Schulze K, von Felden J, Koch S, Schwabl P, Hinrichs JB, Waneck F, Waidmann O, Reiberger T, Müller C, Sieghart W, Trauner M, ... ... Pinter M, et al. Programmed cell death protein-1 (PD-1)-targeted immunotherapy in advanced hepatocellular carcinoma: efficacy and safety data from an international multicentre real-world cohort. Alimentary Pharmacology & Therapeutics. PMID 30980420 DOI: 10.1111/apt.15245 |
0.015 |
|
| 1998 |
PINTER M, CSORBA L, ZEKANY G. [Haemophilus vaginalis in the etiology of colpitis]. Orvosi Hetilap. 103: 585-7. PMID 14486790 |
0.015 |
|
| 2022 |
Bauer D, Kozbial K, Schwabl P, Chromy D, Simbrunner B, Stättermayer AF, Pinter M, Steindl-Munda P, Trauner M, Ferenci P, Reiberger T, Mandorfer M. Angiopoietin 2 levels decrease after HCV-cure and reflect the evolution of portal hypertension. Digestive and Liver Disease : Official Journal of the Italian Society of Gastroenterology and the Italian Association For the Study of the Liver. PMID 35382974 DOI: 10.1016/j.dld.2022.02.013 |
0.014 |
|
| 2022 |
Jachs M, Scheiner B, Pinter M. Immunotherapy for hepatocellular carcinoma in a patient with hepatitis B virus and hepatitis delta virus coinfection. Journal of Hepatology. 77: 256-257. PMID 35124108 DOI: 10.1016/j.jhep.2022.01.017 |
0.014 |
|
| 2019 |
Scheiner B, Kirstein MM, Pinter M. Reply to the Letter to the Editor Entitled "Too Many versus Too Few Platelets in Patients with Hepatocellular Carcinoma: Good or Bad?". Liver Cancer. 9: 110-111. PMID 32071917 DOI: 10.1159/000504301 |
0.014 |
|
| 2003 |
PINTER M, BALAZS V. [Research on etiology and epidemiology of infections with Coxsackie virus in Szeged]. Orvosi Hetilap. 95: 941-5. PMID 14349347 |
0.013 |
|
| 2020 |
Scheiner B, Pinter M. Letter: programmed cell death protein-1 (PD-1)-targeted immunotherapy in advanced hepatocellular carcinoma: efficacy and safety data from an international multicentre real-world cohort-more questions than answers. Authors' reply. Alimentary Pharmacology & Therapeutics. 50: 231-232. PMID 31246367 DOI: 10.1111/apt.15334 |
0.013 |
|
| 2020 |
Scheiner B, Pinter M. Letter: programmed cell death protein-1-targeted immunotherapy for advanced hepatocellular carcinoma-authors' reply. Alimentary Pharmacology & Therapeutics. 50: 341-342. PMID 31313365 DOI: 10.1111/apt.15368 |
0.012 |
|
| 1975 |
Pintér M, Kántor M. Comparison of Alcaligenes faecalis and Alcaligenes odorans var. viridans by carbon source utilization test. Acta Microbiologica Academiae Scientiarum Hungaricae. 21: 293-5. PMID 4432775 |
0.01 |
|
| 2001 |
Pullium JK, Lin PH, Pinter MJ. Homologous transplantation of prepubertal testes in the dog. Transplantation. 72: 552-3. PMID 11502999 |
0.01 |
|
| 2022 |
Scheiner B, Pinter M. Reply to: "The CRAFITY score: a promising prognostic predictor for patients with hepatocellular carcinoma treated with tyrosine kinase inhibitor and immunotherapy combinations". Journal of Hepatology. 77: 576-577. PMID 35526786 DOI: 10.1016/j.jhep.2022.04.030 |
0.01 |
|
| 2011 |
Pinter M, Sieghart W, Reisegger M, Wrba F, Peck-Radosavljevic M. Sorafenib in unresectable intrahepatic cholangiocellular carcinoma: a case report. Wiener Klinische Wochenschrift. 123: 61-4. PMID 21240686 DOI: 10.1007/s00508-010-1522-y |
0.01 |
|
| 2009 |
Cyrany J, Pintér M, Tycová V, Krejsek J, Belada D, Rejchrt S, Bures J. Trimodality imaging of colonic lymphoma. Endoscopy. 41: E1-2. PMID 19177289 DOI: 10.1055/s-2007-995696 |
0.01 |
|
| 2008 |
Pintérová Kolesárová M, Pintér M, Rejchrt S, Douda T, Tachecí I, Kopácová M, Bures J. [The influence of inflammatory bowel disease on the period of conceiving]. Ceská Gynekologie / Ceská LéKarská Spolecnost J. Ev. Purkyne. 73: 109-12. PMID 18567431 |
0.01 |
|
| 2003 |
PINTER M, BALAZS V. Studies on Coxsackie virus infections in Hungary. I. Isolation and identification of Coxsackie virus strains. Acta Microbiologica Academiae Scientiarum Hungaricae. 2: 161-6. PMID 14375840 |
0.01 |
|
| 2003 |
PINTER M, BELADI I. [Tissue culture of encephalitis virus isolated in Czechoslovakia]. Acta Microbiologica Academiae Scientiarum Hungaricae. 1: 243-7. PMID 13180266 |
0.01 |
|
| 2003 |
IVADY G, PINTER M, SZABO M. [Symptomatology of Coxsackie virus infections]. Orvosi Hetilap. 94: 1221-4. PMID 13133418 |
0.01 |
|
| 2003 |
IVANOVICS G, PINTER M. Coxsackie virus infection in Hungary. Acta Medica Academiae Scientiarum Hungaricae. 4: 157-61. PMID 13079584 |
0.01 |
|
| 2003 |
IVANOVICS G, PINTER M. [The first proved Coxsackie virus infection in Hungary]. Orvosi Hetilap. 93: 1452-5. PMID 13046864 |
0.01 |
|
| 2003 |
PINTER M. [Antibodies to the Lansing strain of poliomyelitis virus in sera and colostra in Hungary]. Acta Medica Academiae Scientiarum Hungaricae. 4: 105-10. PMID 13039943 |
0.01 |
|
| 2002 |
ABRAHAM E, PINTER M. Growth of MM virus in human embryonic tissue. Acta Microbiologica Academiae Scientiarum Hungaricae. 3: 405-8. PMID 13354311 |
0.01 |
|
| 1998 |
HUNYA T, DOBIZ I, MOLNAR M, PINTER M. [Therapy of infants with dystrophy by Nerobol]. Gyermekgyogyaszat : Az Orvosegeszsegugyi Szakszervezet Gyermekorvos Szakcsoportjanak Folyoirata = Pediatriia. 14: 10-6. PMID 13955804 |
0.01 |
|
| 1998 |
Filzwieser I, Pinter M. [Why I want to be a pediatric nurse]. Osterreichische Krankenpflegezeitschrift. 51: 29-30. PMID 9512612 |
0.01 |
|
| 1996 |
GYARMATI I, IVANYI J, PINTER M. [FLAVOBACTERIUM AND B. ANITRATUM CAUSING ORAL SEPSIS]. Fogorvosi Szemle. 58: 250-2. PMID 14336486 |
0.01 |
|
| 1996 |
PINTER M, IVANYI J. BACTERIOLOGICAL STANDARDS JUBILEE. British Medical Journal. 1: 1568-9. PMID 14288122 |
0.01 |
|
| 1996 |
PINTER M, IVANYI J. DUST AGGREGATION IN COAL MINER'S LUNG. British Medical Journal. 1: 1568. PMID 14288121 |
0.01 |
|
| 1996 |
PINTER M, IVANYI J. EPIDEMIOLOGY OF STOMACH CANCER. British Medical Journal. 1: 1567-8. PMID 14288120 DOI: 10.1136/bmj.1.5450.1567 |
0.01 |
|
| 1996 |
PINTER M, IVANYI J. RABIES. British Medical Journal. 1: 1565-6. PMID 14288118 DOI: 10.1136/bmj.1.5450.1565 |
0.01 |
|
| 1996 |
PINTER M, IVANYI J. SEPTICAEMIA DUE TO FLAVOBACTERIUM AND MIMA POLYMORPHA. British Medical Journal. 1: 1555. PMID 14288117 DOI: 10.1136/bmj.1.5449.1555-a |
0.01 |
|
| 1988 |
Méhes K, Pintér M, Bajnóczky K. [Screening for X chromatin in newborn girls]. Orvosi Hetilap. 129: 337-8. PMID 3347482 |
0.01 |
|
| 1974 |
Pintér M, Kántor M. [Pseudomonas maltophilia infections]. Orvosi Hetilap. 115: 254-5. PMID 4839507 |
0.01 |
|
| 1971 |
Iványi J, Pintér M. Septicaemia due to acinetobacter strains. Zentralblatt Fur Bakteriologie, Parasitenkunde, Infektionskrankheiten Und Hygiene. Erste Abteilung Originale. Reihe a: Medizinische Mikrobiologie Und Parasitologie. 217: 217-20. PMID 5560791 |
0.01 |
|
| 1971 |
Pintér M, Kántor M. Quantitative antibiotic sensitivity pattern of Acinetobacter strains. Antonie Van Leeuwenhoek. 37: 197-200. PMID 5314553 DOI: 10.1007/BF02218481 |
0.01 |
|
| 1970 |
Pintér M, De Ley J. Overall similarity and DNA base composition of some Acinetobacter strains. Antonie Van Leeuwenhoek. 35: 209-14. PMID 5310447 DOI: 10.1007/BF02219131 |
0.01 |
|
| 1968 |
Iványi J, Pintér M. [The splenogram in acute viral hepatitis]. Acta Hepato-Splenologica. 14: 237-41. PMID 5589689 |
0.01 |
|
| 1968 |
Pintér M, Bende I, Iványi J. [Flavobacterium infections]. Orvosi Hetilap. 108: 1991-2. PMID 5584476 |
0.01 |
|
| 1967 |
Pintér M, Bende I. Computer analysis of Acinetobacter iwoffi (Moraxella iwoffii) and Acinetobacter anitratus (Moraxella glucidolytica) strains. Journal of General Microbiology. 46: 267-72. PMID 6029735 DOI: 10.1099/00221287-46-2-267 |
0.01 |
|
| 1967 |
Iványi J, Pintér M, Libor J, Bende I. [Bacterium anitratum infections in our patients]. Zentralblatt Fur Bakteriologie, Parasitenkunde, Infektionskrankheiten Und Hygiene. 1. Abt. Medizinisch-Hygienische Bakteriologie, Virusforschung Und Parasitologie. Originale. 199: 501-6. PMID 5983615 |
0.01 |
|
| Hide low-probability matches. |